<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>D‐mannose for preventing and treating urinary tract infections - Cooper, TE - 2022 | Cochrane Library</title> <meta content="D‐mannose for preventing and treating urinary tract infections - Cooper, TE - 2022 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013608.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="D‐mannose for preventing and treating urinary tract infections - Cooper, TE - 2022 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013608.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD013608.pub2" name="dc.identifier" scheme="DOI"/> <meta content="D‐mannose for preventing and treating urinary tract infections" name="citation_title"/> <meta content="Tess E Cooper" name="citation_author"/> <meta content="tess.cooper@sydney.edu.au" name="citation_author_email"/> <meta content="Claris Teng" name="citation_author"/> <meta content="Martin Howell" name="citation_author"/> <meta content="Armando Teixeira-Pinto" name="citation_author"/> <meta content="Allison Jaure" name="citation_author"/> <meta content="Germaine Wong" name="citation_author"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="8" name="citation_issue"/> <meta content="10.1002/14651858.CD013608.pub2" name="citation_doi"/> <meta content="2022" name="citation_date"/> <meta content="2022/08/30" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013608.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013608.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013608.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Anti-Bacterial Agents [therapeutic use]; *Bacteriuria [drug therapy]; Kidney; Mannose [therapeutic use]; *Urinary Tract Infections [drug therapy, prevention &amp; control]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013608.pub2&amp;doi=10.1002/14651858.CD013608.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013608.pub2&amp;doi=10.1002/14651858.CD013608.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013608.pub2&amp;doi=10.1002/14651858.CD013608.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013608.pub2&amp;doi=10.1002/14651858.CD013608.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013608.pub2&amp;doi=10.1002/14651858.CD013608.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013608.pub2&amp;doi=10.1002/14651858.CD013608.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013608.pub2&amp;doi=10.1002/14651858.CD013608.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013608.pub2&amp;doi=10.1002/14651858.CD013608.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013608.pub2&amp;doi=10.1002/14651858.CD013608.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013608.pub2&amp;doi=10.1002/14651858.CD013608.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013608.pub2&amp;doi=10.1002/14651858.CD013608.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013608.pub2&amp;doi=10.1002/14651858.CD013608.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013608.pub2&amp;doi=10.1002/14651858.CD013608.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013608.pub2&amp;doi=10.1002/14651858.CD013608.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013608.pub2&amp;doi=10.1002/14651858.CD013608.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013608.pub2&amp;doi=10.1002/14651858.CD013608.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013608.pub2&amp;doi=10.1002/14651858.CD013608.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013608.pub2&amp;doi=10.1002/14651858.CD013608.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013608.pub2&amp;doi=10.1002/14651858.CD013608.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013608.pub2&amp;doi=10.1002/14651858.CD013608.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013608.pub2&amp;doi=10.1002/14651858.CD013608.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013608.pub2&amp;doi=10.1002/14651858.CD013608.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013608.pub2&amp;doi=10.1002/14651858.CD013608.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773519000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773548000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000"}};Liferay.authToken="9mpoajSI";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD013608\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD013608\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013608\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013608\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513680837000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","zh_HANS","zh_HANT","ko","ms","ja","hr","fa","pl","fr"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD013608.pub2",title:"D\\u2010mannose for preventing and treating urinary tract infections",firstPublishedDate:"Aug 30, 2022 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Kidney and Transplant Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734739000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=9mpoajSI&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD013608.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD013608.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD013608.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD013608.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD013608.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD013608.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD013608.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD013608.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD013608.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD013608.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;초록&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;hr&quot;,&quot;title&quot;:&quot;Laički sažetak&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;一般語訳&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;쉬운 말 요약&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;pl&quot;,&quot;title&quot;:&quot;Streszczenie prostym językiem&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;淺顯易懂的口語結論&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD013608.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD013608.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD013608.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD013608.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>30251 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD013608.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013608.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013608.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013608.pub2/full#CD013608-abs-0002"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013608.pub2/full#CD013608-sec-0092"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013608.pub2/full#CD013608-sec-0008"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013608.pub2/full#CD013608-sec-0009"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013608.pub2/full#CD013608-sec-0014"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013608.pub2/full#CD013608-sec-0015"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013608.pub2/full#CD013608-sec-0043"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013608.pub2/full#CD013608-sec-0086"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD013608.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013608.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013608.pub2/appendices#CD013608-sec-0097"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013608.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013608.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD013608.pub2/media/CDSR/CD013608/supinfo/CD013608StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD013608.pub2/media/CDSR/CD013608/supinfo/CD013608StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013608.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013608.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013608.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD013608.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD013608.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD013608.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2022 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD013608.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">D‐mannose for preventing and treating urinary tract infections</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013608.pub2/information#CD013608-cr-0004"><i class="icon corresponding-author fa fa-envelope"></i>Tess E Cooper</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013608.pub2/information#CD013608-cr-0005">Claris Teng</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013608.pub2/information#CD013608-cr-0006">Martin Howell</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013608.pub2/information#CD013608-cr-0007">Armando Teixeira-Pinto</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013608.pub2/information#CD013608-cr-0008">Allison Jaure</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013608.pub2/information#CD013608-cr-0009">Germaine Wong</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD013608.pub2/information/en#CD013608-sec-0105">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 30 August 2022 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD013608.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD013608.pub2">https://doi.org/10.1002/14651858.CD013608.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD013608-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD013608-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD013608-abs-0016">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD013608-abs-0011">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD013608-abs-0014">Français</a> </li> <li class="section-language"> <a class="" href="full/ko#CD013608-abs-0006">한국어</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD013608-abs-0003">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD013608-abs-0001" lang="en"> <section id="CD013608-sec-0001"> <h3 class="title" id="CD013608-sec-0001">Background</h3> <p>Urinary tract infections (UTIs) are very common, affecting more than 7 million people worldwide. Whilst many people may only experience a single episode in their lifetime and are generally responsive to standard antibiotics, a significant proportion of adults and children (approximately 15% to 25%) are chronic symptomatic UTI sufferers. Certain population groups are at greater risk than others, such as immunosuppressed and people with chronic kidney disease. </p> <p>D‐mannose is a sugar part of normal human metabolism found within most diets. The mechanism of action is to prevent bacterial adherence to the uroepithelial cells. The D‐mannose‐based inhibitors can block uropathogenic <i>Escherichia coli</i> adhesion and invasion of the uroepithelial cells. The bacteria are then understood to essentially be eliminated by urination. </p> <p>Early pilot studies on animals and humans have trialled concentrated forms of D‐mannose (tablets or sachets) in doses ranging from 200 mg up to 2 to 3 g and found possible efficacy in reducing UTI symptoms or recurrence. </p> <p>Although the anti‐adhesive effects of D‐mannose have been well‐established, only recently have we seen a small number of pilot studies and small clinical trials conducted. </p> </section> <section id="CD013608-sec-0002"> <h3 class="title" id="CD013608-sec-0002">Objectives</h3> <p>To assess the benefits and harms of D‐mannose for preventing and treating UTIs in adults and children. </p> </section> <section id="CD013608-sec-0003"> <h3 class="title" id="CD013608-sec-0003">Search methods</h3> <p>We searched the Cochrane Kidney and Transplant Register of Studies up to 22 February 2022 through contact with the Information Specialist using search terms relevant to this review. Studies in the Register are identified through searches of CENTRAL, MEDLINE, and EMBASE, conference proceedings, the International Clinical Trials Register (ICTRP) Search Portal and ClinicalTrials.gov. </p> </section> <section id="CD013608-sec-0004"> <h3 class="title" id="CD013608-sec-0004">Selection criteria</h3> <p>We included RCTs measuring and reporting the effect of D‐mannose, in any combination and any formulation, to prevent or treat UTIs in adults and children, females and males, in any setting (including perioperative). </p> <p>Authors independently assessed the retrieved titles and abstracts and, where necessary, the full text to determine which satisfied the inclusion criteria. </p> </section> <section id="CD013608-sec-0005"> <h3 class="title" id="CD013608-sec-0005">Data collection and analysis</h3> <p>Data extraction was independently carried out by two authors using a standard data extraction form. Methodological quality of the included studies was assessed using the Cochrane risk of bias tool. Data entry was carried out by one author and cross‐checked by another author. The certainty of the evidence was assessed using the GRADE approach. </p> </section> <section id="CD013608-sec-0006"> <h3 class="title" id="CD013608-sec-0006">Main results</h3> <p>We included seven RCTs (719 participants) in adult females and males who had either acute cystitis or a history of recurrent (at least two episodes in six months or three episodes in 12 months) UTIs (symptomatic or asymptomatic). Two were prevention studies, four were prevention and treatment studies (two perioperative and one in people with multiple sclerosis), and one was a treatment study. Time periods ranged from 15 days to six months. No two studies were comparable (by dose or treatments), and we could not undertake meta‐analyses. </p> <p>Individual studies reported no clear evidence to determine whether D‐mannose is more or less effective in preventing or treating UTIs. </p> <p>D‐mannose (2 g) had uncertain effects on symptomatic and bacteriuria‐confirmed UTIs when compared to no treatment (1 study, 205 participants; very low certainty evidence) and antibiotics (nitrofurantoin 50 mg) (1 study, 206 participants; very low certainty evidence). D‐mannose, in combination with herbal supplements, had uncertain effects on symptomatic and bacteria‐confirmed UTI and pain when compared to no treatment (1 study, 40 participants; very low certainty evidence). D‐mannose 500 mg plus supplements (N‐acetylcysteine and Morinda citrifolia fruit extract) had uncertain effects on symptomatic and bacteriuria‐confirmed UTIs when compared to an antibiotic (prulifloxacin 400 mg) (1 study, 75 participants; very low certainty evidence). </p> <p>Adverse events were very few and poorly reported; none were serious (mostly diarrhoea and vaginal burning). </p> <p>Overall, the quality of the evidence is poor. Most studies were judged to have unclear or high risk of bias across most domains. Data was sparse and addressed very few outcomes. The GRADE evaluation was rated as very low certainty evidence due to very serious limitations in the study design or execution (high risk of bias across all studies) and sparse data (single study data and small sample sizes). </p> </section> <section id="CD013608-sec-0007"> <h3 class="title" id="CD013608-sec-0007">Authors' conclusions</h3> <p>There is currently little to no evidence to support or refute the use of D‐mannose to prevent or treat UTIs in all populations. </p> <p>This review highlights the severe lack of high‐quality RCTs testing the efficacy of D‐mannose for UTIs in any population. Despite UTIs being one of the most common adult infections (affecting 50% of women at least once in their lifetime) and the growing global antimicrobial resistance, we found very few studies that adequately test this alternative treatment. </p> <p>Future research in this field requires, in the first instance, a single adequately powered RCT comparing D‐mannose with placebo. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD013608-abs-0002" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD013608-abs-0002">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD013608-abs-0017">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD013608-abs-0012">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD013608-abs-0015">Français</a> </li> <li class="section-language"> <a class="" href="full/hr#CD013608-abs-0010">Hrvatski</a> </li> <li class="section-language"> <a class="" href="full/ja#CD013608-abs-0009">日本語</a> </li> <li class="section-language"> <a class="" href="full/ko#CD013608-abs-0007">한국어</a> </li> <li class="section-language"> <a class="" href="full/ms#CD013608-abs-0008">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/pl#CD013608-abs-0013">Polski</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD013608-abs-0004">简体中文</a> </li> <li class="section-language"> <a class="" href="full/zh_HANT#CD013608-abs-0005">繁體中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD013608-abs-0002" lang="en"> <h3>D‐mannose (sugar tablets) for preventing or treating urinary tract infections in adults and children </h3> <p><b>What is the issue?</b> </p> <p>Urinary tract infections (UTIs) are very common around the world. At least 50% of females will have a UTI once in their lifetime. Approximately 15% to 25% of adults and children suffer from repeated and long‐term UTIs. In many people, standard antibiotics do not work. </p> <p>D‐mannose is a sugar which is part of a normal diet and is believed to create a non‐stick surface on the bladder wall, as well as around the bacteria. It is thought that the bacteria is then expelled when urinating, thus preventing the growth of bacteria which leads to an infection inside the bladder or urinary tract. </p> <p><b>What did we do?</b> </p> <p>We reviewed all of the evidence on D‐mannose (tablets or powder) to see whether it can prevent or treat UTIs in adults and children. The evidence is current to 22 February 2022. </p> <p><b>What did we find?</b> </p> <p>We found seven studies enrolling 719 participants, mostly in females who experience recurrent UTIs (at least 2 episodes in 6 months or 3 episodes in 12 months) on a long‐term basis. We could not combine the data because each study investigated different D‐mannose preparations, different populations, and different control groups. We were unable to determine if taking D‐mannose compared to no treatment, other supplements, or antibiotics reduced the number of repeated UTIs. Only a small number of participants experienced diarrhoea or vaginal burning as a side effect. </p> <p>The quality of the evidence is poor. Studies were conducted using poor‐quality methods and did not enrol enough patients. Only two out of the seven studies blinded the participants to the treatment they receive. </p> <p><b>Summary</b> </p> <p>There is not enough evidence to know whether D‐mannose prevents or treats acute or recurrent UTIs. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD013608-sec-0092" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD013608-sec-0092"></div> <h3 class="title" id="CD013608-sec-0093">Implications for practice</h3> <section id="CD013608-sec-0093"> <p>Despite UTIs being one of the most common adult infections (affecting 50% of women at least once in their lifetime), and considering the growing global antimicrobial resistance, we found very few studies that adequately test this alternative treatment. </p> <p>There is currently little to no evidence to support the use of D‐mannose to prevent or treat UTIs. We are not certain whether D‐mannose is effective in preventing or treating UTIs in any population. Adverse events were poorly reported, and of the very few adverse effects reported, none were serious (mostly diarrhoea and vaginal burning). </p> </section> <h3 class="title" id="CD013608-sec-0094">Implications for research</h3> <section id="CD013608-sec-0094"> <p>We have identified an area of significant uncertainty for the efficacy of D‐mannose in preventing or treating people suffering from UTIs. We are uncertain of the efficacy and harms of D‐mannose in preventing or treating UTIs. Future research in this field requires, in the first instance, a single adequately powered RCT comparing D‐mannose with placebo. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD013608-sec-0008" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD013608-sec-0008"></div> <div class="table" id="CD013608-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">D‐mannose (2 g) versus no treatment for preventing or treating urinary tract infections</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>D‐mannose (2 g) versus no treatment for preventing or treating urinary tract infections</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Patient or population:</b> women with acute cystitis or history of recurrent acute cystitis (preventing and treating) </p> <p><b>Settings:</b> general hospital and general practice </p> <p><b>Intervention:</b> D‐mannose (2 g) </p> <p><b>Comparison:</b> no treatment </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>No. of participants<br/>(RCTs)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Quality of the evidence<br/>(GRADE)</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Assumed risk</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>No treatment</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>D‐mannose<br/>(2 g)</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Symptomatic and bacteriuria confirmed UTI (positive culture)</b> </p> <p><b>Follow‐up at 24 weeks</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>608 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>146 per 1000</p> <p>(91 to 237)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.24</p> <p>(0.15 to 0.39)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>205 (1)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>very low<sup>1</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Symptomatic‐only UTI</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>No data</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>No data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Asymptomatic bacteriuria</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>No data</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>No data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Changes to previous treatment regimen</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>No data</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>No data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Pain</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>No data</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>No data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Cure/complete remission</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>No data</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>No data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse effects</b> </p> <p><b>Follow‐up at 24 weeks</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>No events</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>8/103**</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 16.84</p> <p>(0.98 to 287.92)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>205 (1)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>very low<sup>1</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p>** Event rate derived from the raw data. A 'per thousand' rate is non‐informative in view of the scarcity of evidence and zero events in the control group </p> <p><b>CI:</b> Confidence interval; <b>RR:</b> Risk Ratio; <b>UTI:</b> urinary tract infection </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/><b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/><b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/><b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/><b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>1</sup>Downgraded for very serious limitations in the study design or execution (high risk of bias) (‐2), and sparse data (single study data) (‐1) </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD013608-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">D‐mannose (2 g) versus nitrofurantoin (50 mg) for preventing or treating urinary tract infections</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>D‐mannose (2 g) versus nitrofurantoin (50 mg) for preventing or treating urinary tract infections</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Patient or population:</b> women with acute cystitis or history of recurrent acute cystitis (preventing and treating) </p> <p><b>Settings:</b> general hospital and general practice </p> <p><b>Intervention:</b> D‐mannose (2 g) </p> <p><b>Comparison:</b> nitrofurantoin (50 mg) </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>No. of participants<br/>(RCTs)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Quality of the evidence<br/>(GRADE)</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Assumed risk</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>nitrofurantoin<br/>(50 mg)</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>D‐mannose<br/>(2 g)</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Symptomatic and bacteriuria‐confirmed UTI (positive culture)</b> </p> <p><b>Follow‐up at 24 weeks</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>204 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>145 per 1000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.71</p> <p>(0.39 to 1.31)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>206 (1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>very low<sup>1</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Symptomatic only UTI</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>No data</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>No data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Asymptomatic bacteriuria</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>No data</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>No data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Changes to previous treatment regimen</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>No data</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>No data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Pain</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>No data</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>No data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Cure/complete remission</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>No data</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>No data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse effects</b> </p> <p><b>Follow‐up at 24 weeks</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>282 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>79 per 1000</p> <p>(37 to 160)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.28</p> <p>(0.13 to 0.57)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>206 (1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>very low<sup>1</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><b>CI:</b> Confidence interval; <b>RR:</b> Risk Ratio; <b>UTI:</b> urinary tract infection </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/><b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/><b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/><b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/><b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>1</sup>Downgraded for very serious limitations in the study design or execution (high risk of bias) (‐2), and sparse data (single study data) (‐1). </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD013608-sec-0009" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD013608-sec-0009"></div> <section id="CD013608-sec-0010"> <h3 class="title" id="CD013608-sec-0010">Description of the condition</h3> <p>Urinary tract infections (UTIs) are common in the general population globally. Whilst many people may only experience a single episode in their lifetime (at least 50% of females), approximately 15% to 25% of adults (mostly women) and children are chronic symptomatic UTI sufferers under the categories of recurrent (at least 2 episodes in 6 months or 3 episodes in 12 months); persistent (the same pathogen in urine culture); re‐infected (new pathogen in urine culture); or relapsed (initial pathogen in urine culture after it had been eradicated) UTIs. Many cases in clinical practice do not respond to standard antibiotic treatments, creating a significant patient burden and high cost to patients and healthcare systems (<a href="./references#CD013608-bbs2-0020" title="AltaracS , PapešD . Use of d-mannose in prophylaxis of recurrent urinary tract infections (UTIs) in women. BJU International2014;113(1):9-10. [MEDLINE: 24215164]">Altarac 2014</a>; <a href="./references#CD013608-bbs2-0032" title="RoweTA , Juthani-MehtaM . Diagnosis and management of urinary tract infection in older adults. Infectious Disease Clinics of North America2014;28(1):75-89. [MEDLINE: 24484576]">Rowe 2014</a>). </p> <p>Symptomatic bacteriuria is the combination of clinical UTI symptoms often called 'cystitis' (including dysuria, urinary frequency, urgency and suprapubic pain, voiding issues, worsening of symptoms) with a positive quantitative urine culture (as confirmed by a catheter specimen of urine, midstream urine specimen if possible, or a clean‐catch specimen and defined as &gt; 10⁵ colony‐forming units (CFU)/mL, or as defined by authors) (<a href="./references#CD013608-bbs2-0031" title="NicolleLE , BradleyS , ColganR , RiceJC , SchaefferA , HootonTM , et al. Infectious Diseases Society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults [Erratum in: Clin Infect Dis. 2005 May 15;40(10):1556]. Clinical Infectious Diseases2005;40(5):643-54. [MEDLINE: 15714408]">Nicolle 2005</a>; <a href="./references#CD013608-bbs2-0032" title="RoweTA , Juthani-MehtaM . Diagnosis and management of urinary tract infection in older adults. Infectious Disease Clinics of North America2014;28(1):75-89. [MEDLINE: 24484576]">Rowe 2014</a>). </p> <p>Symptomatic UTI is the presence of clinical UTI symptoms 'cystitis' (including dysuria, urinary frequency, urgency and suprapubic pain, voiding issues, worsening of symptoms) without a positive quantitative urine culture (<a href="./references#CD013608-bbs2-0031" title="NicolleLE , BradleyS , ColganR , RiceJC , SchaefferA , HootonTM , et al. Infectious Diseases Society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults [Erratum in: Clin Infect Dis. 2005 May 15;40(10):1556]. Clinical Infectious Diseases2005;40(5):643-54. [MEDLINE: 15714408]">Nicolle 2005</a>; <a href="./references#CD013608-bbs2-0032" title="RoweTA , Juthani-MehtaM . Diagnosis and management of urinary tract infection in older adults. Infectious Disease Clinics of North America2014;28(1):75-89. [MEDLINE: 24484576]">Rowe 2014</a>). </p> <p>Asymptomatic bacteriuria is the presence of bacteria in the urine without signs or symptoms of a UTI (<a href="./references#CD013608-bbs2-0022" title="FoxmanB . Urinary tract infection syndromes: occurrence, recurrence, bacteriology, risk factors, and disease burden. Infectious Disease Clinics of North America2014;28(1):1-13. [MEDLINE: 24484571]">Foxman 2014</a>; <a href="./references#CD013608-bbs2-0031" title="NicolleLE , BradleyS , ColganR , RiceJC , SchaefferA , HootonTM , et al. Infectious Diseases Society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults [Erratum in: Clin Infect Dis. 2005 May 15;40(10):1556]. Clinical Infectious Diseases2005;40(5):643-54. [MEDLINE: 15714408]">Nicolle 2005</a>). Current guidelines still recommend undertaking treatment because asymptomatic bacteriuria is most common in 1% to 6% of pregnant women, 1% to 25% in elderly women and men (mostly in long‐term care facilities), or in people with diabetes, and is associated with pyelonephritis (<a href="./references#CD013608-bbs2-0035" title="US Preventive Services Task Force, OwensDK , DavidsonKW , KristAH , BarryMJ , CabanaM , et al. Screening for asymptomatic bacteriuria in adults: US Preventive Services Task Force recommendation statement. JAMA2019;322(12):1188-94. [MEDLINE: 31550038]">US PSTF 2019</a>). </p> <p>The most common pathogens found in the urogenital tract and bladder which cause UTIs are Enterobacteriaceae: <i>Escherichia coli</i> (<i>E. coli</i>) Proteus, Klebsiella, and Providentia (<a href="./references#CD013608-bbs2-0032" title="RoweTA , Juthani-MehtaM . Diagnosis and management of urinary tract infection in older adults. Infectious Disease Clinics of North America2014;28(1):75-89. [MEDLINE: 24484576]">Rowe 2014</a>). </p> <p>Currently available prophylactic therapy and treatments range from antibiotics, methenamine hippurate salts, topical oestrogen, urine alkalisers, dietary supplements (cranberry or low acidic foods), and lifestyle and behavioural changes (altering sexual activity, personal hygiene, and clothing). Disadvantages of antibiotics, especially long‐term antibiotic prophylaxis, are the risk of increasing bacterial resistance, high costs to the patient, and repeat visits to the healthcare professional (<a href="./references#CD013608-bbs2-0020" title="AltaracS , PapešD . Use of d-mannose in prophylaxis of recurrent urinary tract infections (UTIs) in women. BJU International2014;113(1):9-10. [MEDLINE: 24215164]">Altarac 2014</a>). Whilst these therapies are available and recommended by healthcare professionals, not all are efficacious or evidence‐based, hence the constant prevalence of chronic UTIs. </p> </section> <section id="CD013608-sec-0011"> <h3 class="title" id="CD013608-sec-0011">Description of the intervention</h3> <p>D‐mannose is a sugar which is part of normal human metabolism and is found in most diets. It plays an important role in particular in the glycosylation of most secretory proteins and certain glycoproteins in the human body (<a href="./references#CD013608-bbs2-0027" title="HuX , ShiY , ZhangP , MiaoM , ZhangT , JiangB . D-mannose: properties, production, and applications: an overview. Comprehensive Reviews in Food Science &amp; Food Safety2016;15(4):773-85. [MEDLINE: 33401842]">Hu 2016</a>; <a href="./references#CD013608-bbs2-0028" title="KranjčecB , PapešD , AltaracS . D-mannose powder for prophylaxis of recurrent urinary tract infections in women: a randomized clinical trial. World Journal of Urology2014;32(1):79-84. [MEDLINE: 23633128]">Kranjčec 2014</a>). It has been known for many years to impart beneficial effects on intestinal diseases, diabetes, the immune system, metabolic syndrome, and potentially UTI (<a href="./references#CD013608-bbs2-0027" title="HuX , ShiY , ZhangP , MiaoM , ZhangT , JiangB . D-mannose: properties, production, and applications: an overview. Comprehensive Reviews in Food Science &amp; Food Safety2016;15(4):773-85. [MEDLINE: 33401842]">Hu 2016</a>). </p> <p>Early pilot studies on animals and humans have trialled concentrated forms of D‐mannose (tablets or sachets) in doses ranging from 200 mg (<a href="./references#CD013608-bbs2-0030" title="Lopes De CarvalhoL , FrancavillaG , MottaR , BrichettoG . D-mannose, cranberry and Vitamin C are effective in preventing urinary tract infections in multiple sclerosis subjects (#108). Multiple Sclerosis2012;18(5):S12-3. [EMBASE: 70762266]">Lopes De Carvalho 2012a</a>) up to 2 g (<a href="./references#CD013608-bbs2-0028" title="KranjčecB , PapešD , AltaracS . D-mannose powder for prophylaxis of recurrent urinary tract infections in women: a randomized clinical trial. World Journal of Urology2014;32(1):79-84. [MEDLINE: 23633128]">Kranjčec 2014</a>; <a href="./references#CD013608-bbs2-0006" title="PorruD , ParmigianiA , TinelliC , BarlettaD , ChoussosD , Di FrancoC , et al. Oral D-mannose in recurrent urinary tract infections in women: a pilot study. Journal of Clinical Urology2014;7(3):208-13. [EMBASE: 372993100]">Porru 2014</a>; <a href="./references#CD013608-bbs2-0013" title="Salinas-CasadoJ , Mendez-RubioS , Esteban-FuertesM , Gomez-RodriguezA , Virseda-ChamorroM , Lujan-GalanM , et al. Efficacy and safety of D-mannose (2 g), 24h prolonged release, associated with proanthocyanidin (PAC), versus isolate PAC, in the management of a series of women with recurrent urinary infections [Eficacia y tolerancia terapeutica de la D-manosa (2 g) de liberacion prolongada 24 horas (asociada a proantocianidinas), frente a proantocianidinas aisladas en el manejo de una serie de mujeres con infecciones urinarias recurrentes]. Archivos Espanoles de Urologia2018;71(2):169-77. [MEDLINE: 29521263]">Salinas‐Casado 2018</a>). These studies investigated D‐mannose in different combinations with other plant extracts or pharmacological agents such as arbutin, berberine, birch, cranberry (<i>Vaccinium macrocarpon</i>), proanthocyanidins, forskolin, nitrofurantoin, noxamicina (propolis extract), nitrofurantoin sulfamethoxazole, trimethoprim antibiotics, and vitamin C. Common treatment regimens appear to be daily doses ranging from three to six months duration. The known half‐life of D‐mannose is approximately four hours as it is known to be metabolised rapidly by the human digestive system (<a href="./references#CD013608-bbs2-0027" title="HuX , ShiY , ZhangP , MiaoM , ZhangT , JiangB . D-mannose: properties, production, and applications: an overview. Comprehensive Reviews in Food Science &amp; Food Safety2016;15(4):773-85. [MEDLINE: 33401842]">Hu 2016</a>). Interactions with other treatments are currently uncertain. </p> </section> <section id="CD013608-sec-0012"> <h3 class="title" id="CD013608-sec-0012">How the intervention might work</h3> <p>The theoretical mechanism of action is to prevent bacterial adherence to uroepithelial cells (<a href="./references#CD013608-bbs2-0027" title="HuX , ShiY , ZhangP , MiaoM , ZhangT , JiangB . D-mannose: properties, production, and applications: an overview. Comprehensive Reviews in Food Science &amp; Food Safety2016;15(4):773-85. [MEDLINE: 33401842]">Hu 2016</a>; <a href="./references#CD013608-bbs2-0028" title="KranjčecB , PapešD , AltaracS . D-mannose powder for prophylaxis of recurrent urinary tract infections in women: a randomized clinical trial. World Journal of Urology2014;32(1):79-84. [MEDLINE: 23633128]">Kranjčec 2014</a>). D‐Mannose is a simple sugar (monosaccharide) also commonly found in fruits such as grapes, watermelon, cranberries and apples. Once it is eaten, it will be absorbed relatively quickly into the bloodstream and excreted out via the renal tubular cells in the urine, thus reducing bacterial adhesion to the urothelium. The D‐mannose attaches to the bacteria and prevents it from attaching to the urothelial cells. The D‐mannose‐based inhibitors can block uropathogenic <i>E. coli</i> (UPEC) adhesion and invasion of the uroepithelial cells (<a href="./references#CD013608-bbs2-0028" title="KranjčecB , PapešD , AltaracS . D-mannose powder for prophylaxis of recurrent urinary tract infections in women: a randomized clinical trial. World Journal of Urology2014;32(1):79-84. [MEDLINE: 23633128]">Kranjčec 2014</a>). The bacteria are then understood to essentially be eliminated by urination. </p> </section> <section id="CD013608-sec-0013"> <h3 class="title" id="CD013608-sec-0013">Why it is important to do this review</h3> <p>D‐mannose has been available on the non‐prescription market in tablet and powder form in most western countries for some time. Although the anti‐adhesive effects of D‐mannose have been well‐established, only recently have we seen a small number of pilot studies and small clinical trials being conducted. It is important to assess and summarise this emerging body of evidence to determine its efficacy (currently unknown) and to ensure high‐quality research is being conducted in this field. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD013608-sec-0014" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD013608-sec-0014"></div> <p>To assess the benefits and harms of D‐mannose for preventing and treating UTIs in adults and children. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD013608-sec-0015" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD013608-sec-0015"></div> <section id="CD013608-sec-0016"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD013608-sec-0017"> <h4 class="title">Types of studies</h4> <p>All randomised controlled trials (RCTs) and quasi‐RCTs (RCTs in which allocation to treatment was obtained by alternation, use of alternate medical records, date of birth or other predictable methods) were included. Unblinded, single, and double‐blind trials were included. </p> <p>Cross‐over studies were included, and data from both phases were considered if there was a minimum washout period of seven days. Otherwise, only the results of the first phase were considered for analysis. </p> <p>Abstracts were included. Unpublished clinical trials with online results available were included. </p> <p>Studies in any healthcare setting were included, including hospitals.</p> <p>Excluded study designs: single‐arm studies, commentaries, editorials, and clinical observations. </p> </section> <section id="CD013608-sec-0018"> <h4 class="title">Types of participants</h4> <section id="CD013608-sec-0019"> <h5 class="title">Inclusion criteria</h5> <p> <ul id="CD013608-list-0001"> <li> <p>Adults and children, of any age and sex, in the general population</p> </li> <li> <p>Pregnant, breastfeeding, and perimenopausal women</p> </li> <li> <p>Adults in residential and long‐term care facilities</p> </li> <li> <p>Adults and children seeking prophylaxis for UTI:</p> <ul id="CD013608-list-0002"> <li> <p>with an indwelling catheter or requiring intermittent catheterization</p> </li> <li> <p>with an abnormal urinary tract (e.g. vesicoureteric reflux, urinary obstruction, dysfunctional voiding, pyelonephritis) </p> </li> <li> <p>with asymptomatic bacteriuria</p> </li> </ul> </li> <li> <p>Adults and children seeking treatment for an existing UTI</p> <ul id="CD013608-list-0003"> <li> <p>symptomatic or asymptomatic UTI</p> </li> <li> <p>upper or lower, complicated or uncomplicated UTI</p> </li> </ul> </li> <li> <p>Studies exclusively involving critically ill, renal abnormalities, diagnosed chronic kidney disease (CKD), kidney transplant, or immunosuppressed patients were to be included but analysed separately as subgroups where possible. </p> </li> <li> <p>Studies of patients who have co‐morbidities such as diabetes, multiple sclerosis, cardiovascular diseases, neurological disorders, and serious or rare diseases were to be included but analysed separately as subgroups where possible. </p> </li> <li> <p>Studies of a perioperative nature where UTI prevention or treatment is involved were to be included but analysed separately as subgroups where possible. </p> </li> <li> <p>Studies of mixed populations and applicable data for patients with our UTI criteria were to be extracted where possible. If this is not possible, the study was to be excluded with the reasons provided. </p> </li> </ul> </p> </section> <section id="CD013608-sec-0020"> <h5 class="title">Exclusion criteria</h5> <p> <ul id="CD013608-list-0004"> <li> <p>Adults and children receiving concurrent pharmacological medications for co‐morbidities including, but not limited to the following: </p> <ul id="CD013608-list-0005"> <li> <p>Blood glucose medications</p> </li> <li> <p>Blood pressure medications</p> </li> <li> <p>Immunosuppressants.</p> </li> </ul> </li> <li> <p>Adults and children receiving simultaneous (or in the prior seven days) pharmacological or non‐pharmacological treatments for UTI prevention or treatment which are not of the study criteria including, but not limited to the following: </p> <ul id="CD013608-list-0006"> <li> <p>Antibiotics (either as prophylactic or for treatment of an existing UTI)</p> </li> <li> <p>Prebiotics, probiotics, or synbiotics</p> </li> <li> <p>Cranberry‐based treatments (juice, concentrated tablets, fruit)</p> </li> <li> <p>Diuretics or urinary alkalinization</p> </li> <li> <p>Natural therapies or Traditional Chinese Medicine</p> </li> <li> <p><b>NOTE</b>: these treatments will be accepted as comparison interventions for D‐mannose. </p> </li> </ul> </li> <li> <p>Patients who have signs of systemic illness (such as fever, loin pain, toxicity).</p> </li> </ul> </p> </section> </section> <section id="CD013608-sec-0021"> <h4 class="title">Types of interventions</h4> <p>Studies of prophylaxis and studies of treating existing UTIs were planned to be combined but analysed as subgroups. </p> <p> <ul id="CD013608-list-0007"> <li> <p>Any D‐mannose treatment administered for the prevention or treatment of symptomatic or asymptomatic UTI compared to an active comparator, placebo or no treatment. </p> </li> <li> <p>Any route of administration, dose, duration, or frequency were accepted.</p> </li> <li> <p>Formulations such as oral tablets, liquids, and effervescent powders were accepted.</p> </li> <li> <p>Combination pharmacotherapies (such as D‐mannose plus vitamin or D‐mannose plus cranberry) were accepted and considered as separate treatment arms. </p> </li> </ul> </p> <section id="CD013608-sec-0022"> <h5 class="title">Comparison pairs for analysis</h5> <p> <ul id="CD013608-list-0008"> <li> <p>D‐mannose (dose A) versus D‐mannose (dose B)</p> </li> <li> <p>D‐mannose versus placebo</p> </li> <li> <p>D‐mannose versus no treatment</p> </li> <li> <p>D‐mannose versus other pharmacological treatments such as antibiotics, prebiotics, probiotics, synbiotics </p> </li> <li> <p>D‐mannose versus diuretics or urinary alkalinization</p> </li> <li> <p>D‐mannose versus non‐pharmacological treatment such as vitamin or herbal supplements, cranberry‐based treatments (juice, concentrated tablets, fruit), Traditional Chinese Medicine (TCM), or natural therapies </p> </li> <li> <p>D‐mannose versus combination pharmacotherapies (two or more of any of the above in one treatment arm) </p> </li> <li> <p>D‐mannose in combination with another treatment (two or more of any of the above in one treatment arm) versus any of the above. </p> </li> </ul> </p> <p>Treatment arms where the intervention is in combination with an analgesic were not accepted, such as D‐mannose plus paracetamol, opioids, or an NSAID. </p> </section> </section> <section id="CD013608-sec-0023"> <h4 class="title">Types of outcome measures</h4> <p>This review did not exclude studies based on non‐reporting of outcomes of interest or availability of data. </p> <section id="CD013608-sec-0024"> <h5 class="title">Primary outcomes</h5> <p> <ol id="CD013608-list-0009"> <li> <p>Symptomatic and bacteriuria‐confirmed UTI according to defined clinical symptomatic criteria (including dysuria, urinary frequency, urgency and suprapubic pain, voiding issues, worsening of symptoms), plus a positive quantitative urine culture (as confirmed by a catheter specimen of urine, midstream urine specimen if possible, or a clean catch specimen and defined as &gt; 10⁵ CFU/mL, or as defined by authors), as any of the following measures. </p> <ul id="CD013608-list-0010"> <li> <p>Total number of symptomatic bacteriuria (&gt; 10⁵ CFU/mL) (cystitis or pyelonephritis) in each group following treatment (all time points included) </p> </li> <li> <p>Recurrent symptomatic bacteriuria (&gt; 10⁵ CFU/mL) (cystitis or pyelonephritis) following treatment (all time points included) </p> </li> <li> <p>Persistent symptomatic bacteriuria (&gt; 10⁵ CFU/mL) (cystitis or pyelonephritis) following treatment (all time points included) </p> </li> <li> <p>Re‐infection symptomatic bacteriuria (&gt; 10⁵ CFU/mL) (cystitis or pyelonephritis) following treatment (all time points included) </p> </li> <li> <p>Relapse symptomatic bacteriuria (&gt; 10⁵ CFU/mL) (cystitis or pyelonephritis) following treatment (all time points included) </p> </li> <li> <p>Short‐term reduction in symptomatic bacteriuria episodes and bacteriologically confirmed up to two weeks after the start of treatment </p> </li> <li> <p>Long‐term reduction in symptomatic bacteriuria episodes and bacteriologically confirmed up to eight weeks after the start of treatment. </p> </li> </ul> </li> <li> <p>Symptomatic‐only UTI (dysuria, urinary frequency, urgency and suprapubic pain, voiding issues, worsening of symptoms), with negative urine specimen, as any of the following measures. </p> <ul id="CD013608-list-0011"> <li> <p>Total number of patients who develop urinary symptoms following treatment (all time points included) </p> </li> <li> <p>Recurrent urinary symptoms following treatment (all time points included)</p> </li> <li> <p>Persistence of urinary symptoms following treatment (all time points included)</p> </li> <li> <p>Re‐infection of urinary symptoms following treatment (all time points included)</p> </li> <li> <p>Relapse of urinary symptoms following treatment (all time points included)</p> </li> <li> <p>Short‐term symptomatic cure: the absence of urinary symptoms up to two weeks after the start of treatment </p> </li> <li> <p>Long‐term symptomatic cure: the absence of urinary symptoms up to eight weeks after the start of treatment. </p> </li> </ul> </li> <li> <p>Asymptomatic bacteriuria (irrespective of the presence of symptoms suggestive of UTI). "The number of UTI confirmed by appropriate microbiological criteria. Bacteriuria on quantitative urine analysis of more than 100,000 organisms of a single species per mL is the accepted standard ‐ however, the colony count may vary from 100 to 100,000 depending on the clinical setting (<a href="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003265.pub3/references#CD003265-bbs2-0068" target="_blank">Stamm 1988</a>). Therefore in some situations, (such as a clean suprapubic tap) a colony count of less than 100,000 is acceptable.<i>"</i> (<a href="./references#CD013608-bbs2-0031" title="NicolleLE , BradleyS , ColganR , RiceJC , SchaefferA , HootonTM , et al. Infectious Diseases Society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults [Erratum in: Clin Infect Dis. 2005 May 15;40(10):1556]. Clinical Infectious Diseases2005;40(5):643-54. [MEDLINE: 15714408]">Nicolle 2005</a>). </p> </li> <li> <p>Changes to previous treatment regimen prior to study including antibiotic regimen; reduction in analgesics; or the number of return visits to the GP; probiotics; alternative therapies; reduction in the use of acute and prophylactic antibiotics. </p> </li> <li> <p>Pain (any scale visual analogue scale (VAS)), including neuropathic pain; abdominal or pelvic pain (suprapubic pain, loin pain); other measures of pain. </p> </li> </ol> </p> <section id="CD013608-sec-0025"> <h6 class="title">Definitions</h6> <p> <ul id="CD013608-list-0012"> <li> <p>Re‐infection rate: new pathogen in urine culture.</p> </li> <li> <p>Relapse rate: initial pathogen in urine culture after it had been eradicated.</p> </li> <li> <p>Cure rates: no clinical signs, bacteriological cure rate defined as eradication of bacteria, combined clinical and bacteriological cure rate defined as no clinical signs and eradication of bacteria. </p> </li> </ul> </p> </section> </section> <section id="CD013608-sec-0026"> <h5 class="title">Secondary outcomes</h5> <p> <ol id="CD013608-list-0013"> <li> <p>Cure/complete remission of symptomatic and asymptomatic UTI.</p> </li> <li> <p>Quality of life using any validated scale, including mental and functional status (e.g. confusion, weakness, falls). </p> </li> <li> <p>Life participation (lifestyle impact): days absent from work or school; return to normal activities (or ability to do usual activities). </p> </li> <li> <p>Treatment satisfaction: patient‐reported; healthcare provider‐reported.</p> </li> <li> <p>Treatment adherence.</p> </li> <li> <p>Decline in kidney functional measures, including a reduction in estimated glomerular filtration rate (eGFR); proteinuria, and albuminuria. </p> </li> <li> <p>Adverse events: total adverse events, serious adverse events; withdrawals due to adverse events </p> <ul id="CD013608-list-0014"> <li> <p>These include but are not limited to: rash; diarrhoea; gastrointestinal symptoms; pyelonephritis; urosepsis; liver or renal toxicity; worsening of UTI, progression to complicated UTI; any renal parenchymal damage on DMSA, four to six months following UTI; pregnancy‐related outcomes such as preterm birth, stillbirth, small birthweight, or gestational age. </p> </li> <li> <p>Serious adverse events are considered: fatal, life‐threatening, requiring hospitalisation, intravenous antibiotics, bacteraemia, or fungaemia. </p> </li> <li> <p>Death (any cause); sepsis‐related deaths.</p> </li> </ul> </li> </ol> </p> </section> </section> </section> <section id="CD013608-sec-0027"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD013608-sec-0028"> <h4 class="title">Electronic searches</h4> <p>We searched the <a href="http://kidneyandtransplant.cochrane.org/cochrane-kidney-and-transplant-specialised-register" target="_blank">Cochrane Kidney and Transplant Register of Studies</a> on 22 February 2022 through contact with the Information Specialist using search terms relevant to this review. The Register contains studies identified from the following sources. </p> <p> <ol id="CD013608-list-0015"> <li> <p>Monthly searches of the Cochrane Central Register of Controlled Trials (CENTRAL)</p> </li> <li> <p>Weekly searches of MEDLINE OVID SP</p> </li> <li> <p>Searches of kidney and transplant journals and the proceedings and abstracts from major kidney and transplant conferences </p> </li> <li> <p>Searching the current year of EMBASE OVID SP</p> </li> <li> <p>Weekly current awareness alerts for selected kidney and transplant journals</p> </li> <li> <p>Searches of the International Clinical Trials Register (ICTRP) Search Portal and ClinicalTrials.gov.</p> </li> </ol> </p> <p>Studies contained in the Register are identified through searches of CENTRAL, MEDLINE, and EMBASE based on the scope of Cochrane Kidney and Transplant. Details of search strategies, as well as a list of handsearched journals, conference proceedings and current awareness alerts, are available on the <a href="https://kidneyandtransplant.cochrane.org/cochrane-kidney-and-transplant-specialised-register" target="_blank">Cochrane Kidney and Transplant website</a>. </p> <p>See <a href="./appendices#CD013608-sec-0098">Appendix 1</a> for search terms used in strategies for this review. </p> </section> <section id="CD013608-sec-0029"> <h4 class="title">Searching other resources</h4> <p> <ol id="CD013608-list-0016"> <li> <p>Reference lists of review articles, relevant studies and clinical practice guidelines.</p> </li> <li> <p>Contacting relevant individuals/organisations seeking information about unpublished or incomplete studies. </p> </li> <li> <p>Grey literature sources (e.g. abstracts, dissertations and theses), in addition to those already included in the Cochrane Kidney and Transplant Register of Studies, were not searched. </p> </li> </ol> </p> </section> </section> <section id="CD013608-sec-0030"> <h3 class="title" id="CD013608-sec-0030">Data collection and analysis</h3> <section id="CD013608-sec-0031"> <h4 class="title">Selection of studies</h4> <p>The search strategy described was used to obtain titles and abstracts of studies that may be relevant to the review. The titles and abstracts were screened independently by two authors, who discarded studies that were not applicable; however, studies and reviews that may have included relevant data or information on studies were retained initially. Two authors independently assessed the retrieved abstracts and, where necessary, the full text of these studies to determine which studies satisfied the inclusion criteria. Disagreements were planned to be resolved in consultation with a third author. Results of the search are displayed in a PRISMA study flow chart. </p> </section> <section id="CD013608-sec-0032"> <h4 class="title">Data extraction and management</h4> <p>Data extraction was carried out independently by two authors using standard data extraction forms. Disagreements were to be resolved in consultation with a third author; however, this was not required. Studies reported in non‐English language journals were translated before assessment. Where more than one publication of one study exists, reports were grouped together, and the publication with the most complete data was used in the analyses. Where relevant outcomes were only published in earlier versions, these data were used. Any discrepancy between published versions was planned to be highlighted. </p> </section> <section id="CD013608-sec-0033"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>The following items were independently assessed by two authors using the risk of bias assessment tool (<a href="./references#CD013608-bbs2-0026" title="HigginsJP , ThomasJ , ChandlerJ , CumpstonM , LiT , PageMJ , et al. Cochrane Handbook for Systematic Reviews of Interventions version 6.1 (updated September 2020). Cochrane, 2020. Available from www.training.cochrane.org/handbook.">Higgins 2020</a>) (see <a href="./appendices#CD013608-sec-0099">Appendix 2</a>). </p> <p> <ul id="CD013608-list-0017"> <li> <p>Was there adequate sequence generation (selection bias)?</p> </li> <li> <p>Was allocation adequately concealed (selection bias)?</p> </li> <li> <p>Was knowledge of the allocated interventions adequately prevented during the study?</p> <ul id="CD013608-list-0018"> <li> <p>Participants and personnel (performance bias)</p> </li> <li> <p>Outcome assessors (detection bias)</p> </li> </ul> </li> <li> <p>Were incomplete outcome data adequately addressed (attrition bias)?</p> </li> <li> <p>Are reports of the study free of suggestion of selective outcome reporting (reporting bias)? </p> </li> <li> <p>Was the study apparently free of other problems that could put it at risk of bias?</p> </li> </ul> </p> </section> <section id="CD013608-sec-0034"> <h4 class="title">Measures of treatment effect</h4> <p>For dichotomous outcomes (e.g. death or positive UTI episodes), results were planned to be expressed as risk ratio (RR) to establish a statistical difference, and the number needed to treat for an additional beneficial outcome (NNT) and pooled percentages as absolute measures of effect with 95% confidence intervals (CI). </p> <p>Where continuous scales of measurement were used to assess the effects of treatment (e.g. pain or decline in kidney function), the mean difference (MD) was planned to be used, or the standardised mean difference (SMD) if different scales had been used. </p> <p>Where possible, we planned to use the mean change score from baseline. We anticipated that some studies may only report the mean endpoint score of which we planned to use the final time point available and combine these results with the mean change in score, as long as they were of similar scales. </p> </section> <section id="CD013608-sec-0035"> <h4 class="title">Unit of analysis issues</h4> <p>We only accepted randomisation of the individual participant. For multiple dose studies, we planned to use data for the first dose only. For cross‐over studies, we planned only to use the first phase unless a minimum washout period of seven days had been applied to the study design. The unit of analysis for UTIs was either events or patients analysed separately, depending on what type of data was available. </p> </section> <section id="CD013608-sec-0036"> <h4 class="title">Dealing with missing data</h4> <p>Any further information required from the original author was requested by written correspondence (e.g. emailing the corresponding author), and any relevant information obtained in this manner was included in the review. Evaluation of important numerical data such as screened, randomised patients, as well as intention‐to‐treat, as‐treated, and per‐protocol population, was carefully performed. Attrition rates, for example, drop‐outs, losses to follow‐up and withdrawals were investigated. Issues of missing data and imputation methods (e.g. last‐observation‐carried‐forward) were critically appraised (<a href="./references#CD013608-bbs2-0026" title="HigginsJP , ThomasJ , ChandlerJ , CumpstonM , LiT , PageMJ , et al. Cochrane Handbook for Systematic Reviews of Interventions version 6.1 (updated September 2020). Cochrane, 2020. Available from www.training.cochrane.org/handbook.">Higgins 2020</a>). </p> </section> <section id="CD013608-sec-0037"> <h4 class="title">Assessment of heterogeneity</h4> <p>We planned to first assess the heterogeneity by visual inspection of the forest plot. We planned to quantify statistical heterogeneity using the I² statistic, which describes the percentage of total variation across studies that is due to heterogeneity rather than sampling error (<a href="./references#CD013608-bbs2-0025" title="HigginsJP , ThompsonSG , DeeksJJ , AltmanDG . Measuring inconsistency in meta-analyses. BMJ2003;327(7414):557-60. [MEDLINE: 12958120]">Higgins 2003</a>). A guide to the interpretation of I² values is as follows. </p> <p> <ul id="CD013608-list-0019"> <li> <p>0% to 40%: might not be important.</p> </li> <li> <p>30% to 60%: may represent moderate heterogeneity.</p> </li> <li> <p>50% to 90%: may represent substantial heterogeneity.</p> </li> <li> <p>75% to 100%: considerable heterogeneity.</p> </li> </ul> </p> <p>The importance of the observed value of I² depends on the magnitude and direction of treatment effects and the strength of evidence for heterogeneity (e.g. P‐value from the Chi² test or a confidence interval for I²) (<a href="./references#CD013608-bbs2-0026" title="HigginsJP , ThomasJ , ChandlerJ , CumpstonM , LiT , PageMJ , et al. Cochrane Handbook for Systematic Reviews of Interventions version 6.1 (updated September 2020). Cochrane, 2020. Available from www.training.cochrane.org/handbook.">Higgins 2020</a>). </p> </section> <section id="CD013608-sec-0038"> <h4 class="title">Assessment of reporting biases</h4> <p>If possible, funnel plots were planned to be used to assess for the potential existence of small study bias (<a href="./references#CD013608-bbs2-0026" title="HigginsJP , ThomasJ , ChandlerJ , CumpstonM , LiT , PageMJ , et al. Cochrane Handbook for Systematic Reviews of Interventions version 6.1 (updated September 2020). Cochrane, 2020. Available from www.training.cochrane.org/handbook.">Higgins 2020</a>). </p> </section> <section id="CD013608-sec-0039"> <h4 class="title">Data synthesis</h4> <p>Data was planned to be pooled using the random‐effects model, but the fixed‐effect model would also be used to ensure the robustness of the model chosen and susceptibility to outliers. </p> </section> <section id="CD013608-sec-0040"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>Subgroup analysis was planned to be used to explore possible sources of heterogeneity where there were sufficient data. Heterogeneity among participants could be related to age, co‐morbidities, and urological or renal pathologies. Heterogeneity in treatments could be related to the prior agent(s) used and the agent, dose and duration of therapy. Adverse effects were tabulated and assessed with descriptive techniques, as they are likely to be different for the various agents used. Where possible, we planned to use the risk difference with 95% CI to calculate each adverse effect, either compared to no treatment or to another agent. </p> <p>Planned subgroups where sufficient data are available.</p> <p> <ul id="CD013608-list-0020"> <li> <p>Dose</p> </li> <li> <p>Time point</p> </li> <li> <p>Prevention versus treatment of UTI</p> </li> <li> <p>CKD present</p> </li> <li> <p>Age.</p> </li> </ul> </p> </section> <section id="CD013608-sec-0041"> <h4 class="title">Sensitivity analysis</h4> <p>We planned to perform sensitivity analyses in order to explore the influence of the following factors on effect size; however, this was not possible. </p> <p> <ul id="CD013608-list-0021"> <li> <p>Repeating the analysis excluding unpublished studies.</p> </li> <li> <p>Repeating the analysis taking into account the risk of bias, as specified.</p> </li> <li> <p>Repeating the analysis, excluding any very long or large studies to establish how much they dominate the results. </p> </li> <li> <p>Repeating the analysis excluding studies using the following filters: diagnostic criteria, the language of publication, source of funding (industry versus other), and country. </p> </li> </ul> </p> </section> <section id="CD013608-sec-0042"> <h4 class="title">Summary of findings and assessment of the certainty of the evidence</h4> <p>We presented the main results of the review in 'Summary of findings' tables. These tables present key information concerning the certainty of the evidence, the magnitude of the effects of the interventions examined, and the sum of the available data for the main outcomes (<a href="./references#CD013608-bbs2-0033" title="SchünemannHJ , HigginsJP , VistGE , GlasziouP , AklEA , SkoetzN , et al. Chapter 14: Completing ‘Summary of findings’ tables and grading the certainty of the evidence. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.1 (updated September 2020). Cochrane, 2020. www.training.cochrane.org/handbook.">Schunemann 2020a</a>). </p> <p>The 'Summary of findings' tables also includes an overall grading of the evidence related to each of the main outcomes using the GRADE (Grades of Recommendation, Assessment, Development and Evaluation) approach (<a href="./references#CD013608-bbs2-0023" title="GuyattGH , OxmanAD , VistGE , KunzR , Falck-YtterY , Alonso-CoelloP , et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ2008;336(7650):924-6. [MEDLINE: 18436948]">GRADE 2008</a>; <a href="./references#CD013608-bbs2-0024" title="GuyattG , OxmanAD , AklEA , KunzR , VistG , BrozekJ , et al. GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. Journal of Clinical Epidemiology2011;64(4):383-94. [MEDLINE: 21195583]">GRADE 2011</a>). The GRADE approach defines the certainty of a body of evidence as the extent to which one can be confident that an estimate of effect or association is close to the true quantity of specific interest. This was assessed by two authors. A summary of the assessment process is in <a href="./appendices#CD013608-sec-0100">Appendix 3</a>. The certainty of a body of evidence involves consideration of the within‐trial risk of bias (methodological quality), directness of evidence, heterogeneity, the precision of effect estimates and risk of publication bias (<a href="./references#CD013608-bbs2-0034" title="SchünemannHJ , VistGE , HigginsJP , SantessoN , DeeksJJ , GlasziouP , et al. Chapter 15: Interpreting results and drawing conclusions. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.1 (updated September 2020). Cochrane, 2020. Available from www.training.cochrane.org/handbook.">Schunemann 2020b</a>). We planned to present the following outcomes in the 'Summary of findings' tables. </p> <p> <ul id="CD013608-list-0022"> <li> <p>Symptomatic and bacteria‐confirmed UTI</p> </li> <li> <p>Symptomatic only UTI</p> </li> <li> <p>Asymptomatic bacteriuria</p> </li> <li> <p>Changes to previous treatment regimen</p> </li> <li> <p>Pain</p> </li> <li> <p>Cure/complete remission</p> </li> <li> <p>Adverse effects.</p> </li> </ul> </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD013608-sec-0043" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD013608-sec-0043"></div> <section id="CD013608-sec-0044"> <h3 class="title">Description of studies</h3> <section id="CD013608-sec-0045"> <h4 class="title">Results of the search</h4> <p>The PRISMA flow diagram is shown in <a href="#CD013608-fig-0001">Figure 1</a>. </p> <div class="figure" id="CD013608-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD013608-fig-0001" src="/cdsr/doi/10.1002/14651858.CD013608.pub2/media/CDSR/CD013608/image_n/nCD013608-FIG-01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> <p>The search of the register up to 22 February 2022 retrieved 24 records. After title and abstract review, four records were excluded (not RCT, wrong population or intervention/comparator). After full‐text review of the remaining 20 records, seven studies (8 records) were included (<a href="./references#CD013608-bbs2-0001" title="De LeoV , CappelliV , MassaroMG , TostiC , MorganteG . Evaluation of the effects of a natural dietary supplement with cranberry, Noxamicina ® and D-mannose in recurrent urinary infections in perimenopausal women. Minerva Ginecologica2017;69(4):336-41. [MEDLINE: 28608666]">De Leo 2017</a>; <a href="./references#CD013608-bbs2-0002" title="AltaracS , PapesD . Use of D-mannose in prophylaxis of recurrent urinary tract infections (UTIs) in women. BJU International2014;113(1):9-10. [MEDLINE: 24215164]KranjcecB , PapesD , AltaracS . D-mannose powder for prophylaxis of recurrent urinary tract infections in women: a randomized clinical trial. World Journal of Urology2014;32(1):79-84. [MEDLINE: 23633128]">Kranjcec 2014</a>; <a href="./references#CD013608-bbs2-0003" title="KuzmenkoAV , KuzmenkoVV , GyaurgievTA . Efficacy of combined antibacterial-prebiotic therapy in combination with D-mannose in women with uncomplicated lower urinary tract infection. Urologiia2019;(6):38-43. [MEDLINE: 32003165]">Kuzmenko 2019</a>; <a href="./references#CD013608-bbs2-0004" title="Lopes De CarvalhoL , FrancavillaG , MottaR , BrichettoG . D-mannose, cranberry and Vitamin C are effective in preventing urinary tract infections in multiple sclerosis subjects [abstract no: 108]. Multiple Sclerosis2012;18(5):S12-3. [EMBASE: 70762266]">Lopes de Carvalho 2012</a>; <a href="./references#CD013608-bbs2-0005" title="PalleschiG , CarboneA , ZanelloPP , MeleR , LetoA , FuschiA , et al. Prospective study to compare antibiosis versus the association of N-acetylcysteine, D-mannose and Morinda citrifolia fruit extract in preventing urinary tract infections in patients submitted to urodynamic investigation. Archivio Italiano di Urologia, Andrologia2017;89(1):45-50. [MEDLINE: 28403598]">Palleschi 2017</a>; <a href="./references#CD013608-bbs2-0006" title="PorruD , ParmigianiA , TinelliC , BarlettaD , ChoussosD , Di FrancoC , et al. Oral D-mannose in recurrent urinary tract infections in women: a pilot study. Journal of Clinical Urology2014;7(3):208-13. [EMBASE: 372993100]">Porru 2014</a>; <a href="./references#CD013608-bbs2-0007" title="RussoE , Montt GuevaraM , GianniniA , MannellaP , PallaG , CarettoM , et al. Cranberry, D-mannose and anti-inflammatory agents prevent lower urinary tract symptoms in women undergoing prolapse surgery. Climacteric2019;23(2):201-5. [MEDLINE: 31674202]">Russo 2019</a>), six were excluded (<a href="./references#CD013608-bbs2-0008" title="DomeniciL , MontiM , BracchiC , GiorginiM , ColagiovanniV , MuziiL , et al. D-mannose: a promising support for acute urinary tract infections in women. A pilot study. European Review for Medical &amp; Pharmacological Sciences2016;20(13):2920-5. [MEDLINE: 27424995]">Domenici 2016</a>; <a href="./references#CD013608-bbs2-0009" title="GenoveseC , DavinelliS , ManganoK , TemperaG , NicolosiD , CorselloS , et al. Effects of a new combination of plant extracts plus d-mannose for the management of uncomplicated recurrent urinary tract infections. Journal of Chemotherapy2018;30(2):107-14. [MEDLINE: 29078739]">Genovese 2018</a>; <a href="./references#CD013608-bbs2-0010" title="RyuG . Preventing recurrent urinary tract infections with a-d-mannose (PUTIM) [Preventing recurrent urinary tract infections with α-D-mannose: a prospective, randomized, double-blinded placebo-controlled trial]. www.clinicaltrials.gov/show/NCT03497598 (first received 13 April 2018). ">NCT03497598</a>; <a href="./references#CD013608-bbs2-0011" title="ChuC . Methenamine in a non-antibiotic, multimodal approach to UTI prevention [The efficacy and effect of methenamine hippurate in a non-antibiotic, multimodal approach to UTI prevention]. www.clinicaltrials.gov/show/NCT03996057 (first received 24 June 2019). ">NCT03996057</a>; <a href="./references#CD013608-bbs2-0012" title="RadulescuD , DavidC , TurcuFL , SpataruDM , PopescuP , VacaroiuIA . Combination of cranberry extract and D-mannose - possible enhancer of uropathogen sensitivity to antibiotics in acute therapy of urinary tract infections: results of a pilot study. Experimental &amp; Therapeutic Medicine2020;20(4):3399-406. [MEDLINE: 32905041]">Radulescu 2020</a>; <a href="./references#CD013608-bbs2-0013" title="Salinas-CasadoJ , Mendez-RubioS , Esteban-FuertesM , Gomez-RodriguezA , Virseda-ChamorroM , Lujan-GalanM , et al. Efficacy and safety of D-mannose (2 g), 24h prolonged release, associated with proanthocyanidin (PAC), versus isolate PAC, in the management of a series of women with recurrent urinary infections [Eficacia y tolerancia terapeutica de la D-manosa (2 g) de liberacion prolongada 24 horas (asociada a proantocianidinas), frente a proantocianidinas aisladas en el manejo de una serie de mujeres con infecciones urinarias recurrentes]. Archivos Espanoles de Urologia2018;71(2):169-77. [MEDLINE: 29521263]">Salinas‐Casado 2018</a>), and six studies are ongoing (<a href="./references#CD013608-bbs2-0014" title="SubramanianS . D-mannose for prophylaxis against urinary tract Infection in spinal cord injury [D-mannose for prophylaxis against urinary tract Infection in SCI: pilot randomised control study]. www.anzctr.org.au/ACTRN12616001619437.aspx (first received 23 November 2016). ">ACTRN12616001619437</a>; <a href="./references#CD013608-bbs2-0015" title="PattonV . The effectiveness of D-Mannose in patients with high risk of recurrent urinary tract infections. www.anzctr.org.au/ACTRN12619000183189.aspx (first received 8 February 2019). ">ACTRN12619000183189</a>; <a href="./references#CD013608-bbs2-0016" title="HellemannM . Effects of a food for special medical purposes containing d-mannose, birch extract, vitamin D and vitamin A for the dietary management of acute symptomatic uncomplicated urinary tract infections in females - a randomized, double-blind, placebo-controlled, parallel-design study. www.trialsearch.who.int/Trial2.aspx?TrialID=DRKS00013240 (first received 11 June 2017). [CENTRAL: CN-01890405] ">DRKS00013240</a>; <a href="./references#CD013608-bbs2-0017" title="FranssenM , CookJ , RobinsonJ , WilliamsN , GlogowskaM , YangY , et al. D-MannosE to prevent Recurrent urinary tract InfecTions (MERIT): protocol for a randomised controlled trial. BMJ Open2021;11(1):e037128. [MEDLINE: 33441350]">MERIT 2021</a>; <a href="./references#CD013608-bbs2-0018" title="D'AnnaR . Nutritional supplementation for recurrent urinary tract infections in women [Nutritional supplementation for extending time between recurrent urinary tract infections in women: a randomized double blind cross-over trial]. www.clinicaltrials.gov/show/NCT03597152 (first received 24 July 2018). ">NCT03597152</a>; <a href="./references#CD013608-bbs2-0019" title="FlachJ . Winclove CLEAR for recurrent urinary tract infections in women [A randomized, placebo-controlled, pilot study to evaluate the effects winclove CLEAR in female recurrent urinary tract infection patients]. www.trialregister.nl/trial/6832 (first received 25 January 2018). ">PROTON 2018</a>) (target number of participants: 1078). We will include these studies in a future update of this review. </p> </section> <section id="CD013608-sec-0046"> <h4 class="title">Included studies</h4> <p>Seven studies (719 participants) were included See <a href="./references#CD013608-sec-0111" title="">Characteristics of included studies</a>. </p> <p>One study compared a cross‐over treatment with no washout period (<a href="./references#CD013608-bbs2-0006" title="PorruD , ParmigianiA , TinelliC , BarlettaD , ChoussosD , Di FrancoC , et al. Oral D-mannose in recurrent urinary tract infections in women: a pilot study. Journal of Clinical Urology2014;7(3):208-13. [EMBASE: 372993100]">Porru 2014</a>); one study was double‐blind (<a href="./references#CD013608-bbs2-0004" title="Lopes De CarvalhoL , FrancavillaG , MottaR , BrichettoG . D-mannose, cranberry and Vitamin C are effective in preventing urinary tract infections in multiple sclerosis subjects [abstract no: 108]. Multiple Sclerosis2012;18(5):S12-3. [EMBASE: 70762266]">Lopes de Carvalho 2012</a>), and the remaining five were open‐label studies. </p> <p>Sample sizes range from 21 (<a href="./references#CD013608-bbs2-0004" title="Lopes De CarvalhoL , FrancavillaG , MottaR , BrichettoG . D-mannose, cranberry and Vitamin C are effective in preventing urinary tract infections in multiple sclerosis subjects [abstract no: 108]. Multiple Sclerosis2012;18(5):S12-3. [EMBASE: 70762266]">Lopes de Carvalho 2012</a>) to 308 participants (<a href="./references#CD013608-bbs2-0002" title="AltaracS , PapesD . Use of D-mannose in prophylaxis of recurrent urinary tract infections (UTIs) in women. BJU International2014;113(1):9-10. [MEDLINE: 24215164]KranjcecB , PapesD , AltaracS . D-mannose powder for prophylaxis of recurrent urinary tract infections in women: a randomized clinical trial. World Journal of Urology2014;32(1):79-84. [MEDLINE: 23633128]">Kranjcec 2014</a>). The studies took place in either primary care/general practitioners or hospital outpatient settings in Croatia, Italy, Russia, and Spain. Two studies investigated both females and males (<a href="./references#CD013608-bbs2-0004" title="Lopes De CarvalhoL , FrancavillaG , MottaR , BrichettoG . D-mannose, cranberry and Vitamin C are effective in preventing urinary tract infections in multiple sclerosis subjects [abstract no: 108]. Multiple Sclerosis2012;18(5):S12-3. [EMBASE: 70762266]">Lopes de Carvalho 2012</a>; <a href="./references#CD013608-bbs2-0005" title="PalleschiG , CarboneA , ZanelloPP , MeleR , LetoA , FuschiA , et al. Prospective study to compare antibiosis versus the association of N-acetylcysteine, D-mannose and Morinda citrifolia fruit extract in preventing urinary tract infections in patients submitted to urodynamic investigation. Archivio Italiano di Urologia, Andrologia2017;89(1):45-50. [MEDLINE: 28403598]">Palleschi 2017</a>), and the remaining four studies investigated females only. </p> <section id="CD013608-sec-0047"> <h5 class="title">Population</h5> <p>The health status and inclusion criteria for participants varied:</p> <p> <ul id="CD013608-list-0023"> <li> <p>Acute cystitis (single or recurrent) (<a href="./references#CD013608-bbs2-0002" title="AltaracS , PapesD . Use of D-mannose in prophylaxis of recurrent urinary tract infections (UTIs) in women. BJU International2014;113(1):9-10. [MEDLINE: 24215164]KranjcecB , PapesD , AltaracS . D-mannose powder for prophylaxis of recurrent urinary tract infections in women: a randomized clinical trial. World Journal of Urology2014;32(1):79-84. [MEDLINE: 23633128]">Kranjcec 2014</a>; <a href="./references#CD013608-bbs2-0003" title="KuzmenkoAV , KuzmenkoVV , GyaurgievTA . Efficacy of combined antibacterial-prebiotic therapy in combination with D-mannose in women with uncomplicated lower urinary tract infection. Urologiia2019;(6):38-43. [MEDLINE: 32003165]">Kuzmenko 2019</a>) </p> </li> <li> <p>Multiple sclerosis (<a href="./references#CD013608-bbs2-0004" title="Lopes De CarvalhoL , FrancavillaG , MottaR , BrichettoG . D-mannose, cranberry and Vitamin C are effective in preventing urinary tract infections in multiple sclerosis subjects [abstract no: 108]. Multiple Sclerosis2012;18(5):S12-3. [EMBASE: 70762266]">Lopes de Carvalho 2012</a>) </p> </li> <li> <p>Undergoing a mini‐invasive urological diagnostic procedure (<a href="./references#CD013608-bbs2-0005" title="PalleschiG , CarboneA , ZanelloPP , MeleR , LetoA , FuschiA , et al. Prospective study to compare antibiosis versus the association of N-acetylcysteine, D-mannose and Morinda citrifolia fruit extract in preventing urinary tract infections in patients submitted to urodynamic investigation. Archivio Italiano di Urologia, Andrologia2017;89(1):45-50. [MEDLINE: 28403598]">Palleschi 2017</a>) </p> </li> <li> <p>Acute symptomatic UTI (single or recurrent) (<a href="./references#CD013608-bbs2-0006" title="PorruD , ParmigianiA , TinelliC , BarlettaD , ChoussosD , Di FrancoC , et al. Oral D-mannose in recurrent urinary tract infections in women: a pilot study. Journal of Clinical Urology2014;7(3):208-13. [EMBASE: 372993100]">Porru 2014</a>) </p> </li> <li> <p>Postmenopausal women with symptomatic isolated anterior prolapse POP Q stage ≥ III submitted to native tissue repair for cystocele (<a href="./references#CD013608-bbs2-0007" title="RussoE , Montt GuevaraM , GianniniA , MannellaP , PallaG , CarettoM , et al. Cranberry, D-mannose and anti-inflammatory agents prevent lower urinary tract symptoms in women undergoing prolapse surgery. Climacteric2019;23(2):201-5. [MEDLINE: 31674202]">Russo 2019</a>;). </p> </li> </ul> </p> <p>Two studies were undertaken in the perioperative period (<a href="./references#CD013608-bbs2-0005" title="PalleschiG , CarboneA , ZanelloPP , MeleR , LetoA , FuschiA , et al. Prospective study to compare antibiosis versus the association of N-acetylcysteine, D-mannose and Morinda citrifolia fruit extract in preventing urinary tract infections in patients submitted to urodynamic investigation. Archivio Italiano di Urologia, Andrologia2017;89(1):45-50. [MEDLINE: 28403598]">Palleschi 2017</a>; <a href="./references#CD013608-bbs2-0007" title="RussoE , Montt GuevaraM , GianniniA , MannellaP , PallaG , CarettoM , et al. Cranberry, D-mannose and anti-inflammatory agents prevent lower urinary tract symptoms in women undergoing prolapse surgery. Climacteric2019;23(2):201-5. [MEDLINE: 31674202]">Russo 2019</a>). </p> </section> <section id="CD013608-sec-0048"> <h5 class="title">Interventions and comparators</h5> <p><a href="./appendices#CD013608-sec-0101">Appendix 4</a> summarises the comparison pairs and intervention details of the included studies. No studies were similar in drug, dose, comparison, or time point. </p> </section> <section id="CD013608-sec-0049"> <h5 class="title">Outcomes</h5> <p>All seven studies reported data on the three primary outcomes (symptomatic and bacteriuria‐confirmed UTI, symptomatic only UTI, pain) using different units of analysis, different measurement scales, and a combination of prevention or treatment for UTI. <a href="./references#CD013608-bbs2-0003" title="KuzmenkoAV , KuzmenkoVV , GyaurgievTA . Efficacy of combined antibacterial-prebiotic therapy in combination with D-mannose in women with uncomplicated lower urinary tract infection. Urologiia2019;(6):38-43. [MEDLINE: 32003165]">Kuzmenko 2019</a> did not report suitable quantitative data to report in this review (abstract only). </p> <p> <ul id="CD013608-list-0024"> <li> <p>Prevention of UTI: two studies (both in a perioperative setting) <a href="./references#CD013608-bbs2-0005" title="PalleschiG , CarboneA , ZanelloPP , MeleR , LetoA , FuschiA , et al. Prospective study to compare antibiosis versus the association of N-acetylcysteine, D-mannose and Morinda citrifolia fruit extract in preventing urinary tract infections in patients submitted to urodynamic investigation. Archivio Italiano di Urologia, Andrologia2017;89(1):45-50. [MEDLINE: 28403598]">Palleschi 2017</a>; <a href="./references#CD013608-bbs2-0007" title="RussoE , Montt GuevaraM , GianniniA , MannellaP , PallaG , CarettoM , et al. Cranberry, D-mannose and anti-inflammatory agents prevent lower urinary tract symptoms in women undergoing prolapse surgery. Climacteric2019;23(2):201-5. [MEDLINE: 31674202]">Russo 2019</a>) </p> </li> <li> <p>Treatment of UTI: one study (<a href="./references#CD013608-bbs2-0003" title="KuzmenkoAV , KuzmenkoVV , GyaurgievTA . Efficacy of combined antibacterial-prebiotic therapy in combination with D-mannose in women with uncomplicated lower urinary tract infection. Urologiia2019;(6):38-43. [MEDLINE: 32003165]">Kuzmenko 2019</a>) </p> </li> <li> <p>Prevention and treatment of UTI: four studies (<a href="./references#CD013608-bbs2-0001" title="De LeoV , CappelliV , MassaroMG , TostiC , MorganteG . Evaluation of the effects of a natural dietary supplement with cranberry, Noxamicina ® and D-mannose in recurrent urinary infections in perimenopausal women. Minerva Ginecologica2017;69(4):336-41. [MEDLINE: 28608666]">De Leo 2017</a>; <a href="./references#CD013608-bbs2-0002" title="AltaracS , PapesD . Use of D-mannose in prophylaxis of recurrent urinary tract infections (UTIs) in women. BJU International2014;113(1):9-10. [MEDLINE: 24215164]KranjcecB , PapesD , AltaracS . D-mannose powder for prophylaxis of recurrent urinary tract infections in women: a randomized clinical trial. World Journal of Urology2014;32(1):79-84. [MEDLINE: 23633128]">Kranjcec 2014</a>; <a href="./references#CD013608-bbs2-0004" title="Lopes De CarvalhoL , FrancavillaG , MottaR , BrichettoG . D-mannose, cranberry and Vitamin C are effective in preventing urinary tract infections in multiple sclerosis subjects [abstract no: 108]. Multiple Sclerosis2012;18(5):S12-3. [EMBASE: 70762266]">Lopes de Carvalho 2012</a>; <a href="./references#CD013608-bbs2-0006" title="PorruD , ParmigianiA , TinelliC , BarlettaD , ChoussosD , Di FrancoC , et al. Oral D-mannose in recurrent urinary tract infections in women: a pilot study. Journal of Clinical Urology2014;7(3):208-13. [EMBASE: 372993100]">Porru 2014</a>). The baseline population of these studies at enrolment indicated that the patient population had either (a) an acute symptomatic and/or bacteriuria culture‐confirmed UTI or (b) a history of recurrent UTI or symptomatic cystitis as one or more episodes of UTIs documented in the preceding 12 months. </p> </li> </ul> </p> <p>Treatment periods ranged from 15 days (<a href="./references#CD013608-bbs2-0005" title="PalleschiG , CarboneA , ZanelloPP , MeleR , LetoA , FuschiA , et al. Prospective study to compare antibiosis versus the association of N-acetylcysteine, D-mannose and Morinda citrifolia fruit extract in preventing urinary tract infections in patients submitted to urodynamic investigation. Archivio Italiano di Urologia, Andrologia2017;89(1):45-50. [MEDLINE: 28403598]">Palleschi 2017</a>) to 24 weeks (<a href="./references#CD013608-bbs2-0002" title="AltaracS , PapesD . Use of D-mannose in prophylaxis of recurrent urinary tract infections (UTIs) in women. BJU International2014;113(1):9-10. [MEDLINE: 24215164]KranjcecB , PapesD , AltaracS . D-mannose powder for prophylaxis of recurrent urinary tract infections in women: a randomized clinical trial. World Journal of Urology2014;32(1):79-84. [MEDLINE: 23633128]">Kranjcec 2014</a>). </p> </section> </section> <section id="CD013608-sec-0050"> <h4 class="title">Excluded studies</h4> <p>See <a href="./references#CD013608-sec-0112" title="">Characteristics of excluded studies</a>. </p> <p> <ul id="CD013608-list-0025"> <li> <p><a href="./references#CD013608-bbs2-0008" title="DomeniciL , MontiM , BracchiC , GiorginiM , ColagiovanniV , MuziiL , et al. D-mannose: a promising support for acute urinary tract infections in women. A pilot study. European Review for Medical &amp; Pharmacological Sciences2016;20(13):2920-5. [MEDLINE: 27424995]">Domenici 2016</a>: inappropriate and unclear baseline population </p> </li> <li> <p><a href="./references#CD013608-bbs2-0009" title="GenoveseC , DavinelliS , ManganoK , TemperaG , NicolosiD , CorselloS , et al. Effects of a new combination of plant extracts plus d-mannose for the management of uncomplicated recurrent urinary tract infections. Journal of Chemotherapy2018;30(2):107-14. [MEDLINE: 29078739]">Genovese 2018</a>: incomparable treatment arms </p> </li> <li> <p><a href="./references#CD013608-bbs2-0010" title="RyuG . Preventing recurrent urinary tract infections with a-d-mannose (PUTIM) [Preventing recurrent urinary tract infections with α-D-mannose: a prospective, randomized, double-blinded placebo-controlled trial]. www.clinicaltrials.gov/show/NCT03497598 (first received 13 April 2018). ">NCT03497598</a>: terminated due to insufficient patients </p> </li> <li> <p><a href="./references#CD013608-bbs2-0011" title="ChuC . Methenamine in a non-antibiotic, multimodal approach to UTI prevention [The efficacy and effect of methenamine hippurate in a non-antibiotic, multimodal approach to UTI prevention]. www.clinicaltrials.gov/show/NCT03996057 (first received 24 June 2019). ">NCT03996057</a>: D‐mannose with or without methenamine for the UTI prevention </p> </li> <li> <p><a href="./references#CD013608-bbs2-0012" title="RadulescuD , DavidC , TurcuFL , SpataruDM , PopescuP , VacaroiuIA . Combination of cranberry extract and D-mannose - possible enhancer of uropathogen sensitivity to antibiotics in acute therapy of urinary tract infections: results of a pilot study. Experimental &amp; Therapeutic Medicine2020;20(4):3399-406. [MEDLINE: 32905041]">Radulescu 2020</a>: inappropriate intervention and study design phases </p> </li> <li> <p><a href="./references#CD013608-bbs2-0013" title="Salinas-CasadoJ , Mendez-RubioS , Esteban-FuertesM , Gomez-RodriguezA , Virseda-ChamorroM , Lujan-GalanM , et al. Efficacy and safety of D-mannose (2 g), 24h prolonged release, associated with proanthocyanidin (PAC), versus isolate PAC, in the management of a series of women with recurrent urinary infections [Eficacia y tolerancia terapeutica de la D-manosa (2 g) de liberacion prolongada 24 horas (asociada a proantocianidinas), frente a proantocianidinas aisladas en el manejo de una serie de mujeres con infecciones urinarias recurrentes]. Archivos Espanoles de Urologia2018;71(2):169-77. [MEDLINE: 29521263]">Salinas‐Casado 2018</a>: inappropriate intervention arms </p> </li> </ul> </p> <section id="CD013608-sec-0051"> <h5 class="title">Ongoing studies</h5> <p>See <a href="./references#CD013608-sec-0113" title="">Characteristics of ongoing studies</a>. </p> <p> <ul id="CD013608-list-0026"> <li> <p><a href="./references#CD013608-bbs2-0014" title="SubramanianS . D-mannose for prophylaxis against urinary tract Infection in spinal cord injury [D-mannose for prophylaxis against urinary tract Infection in SCI: pilot randomised control study]. www.anzctr.org.au/ACTRN12616001619437.aspx (first received 23 November 2016). ">ACTRN12616001619437</a>: D‐mannose for prophylaxis against UTI in spinal cord injury (target number: 40) </p> </li> <li> <p><a href="./references#CD013608-bbs2-0015" title="PattonV . The effectiveness of D-Mannose in patients with high risk of recurrent urinary tract infections. www.anzctr.org.au/ACTRN12619000183189.aspx (first received 8 February 2019). ">ACTRN12619000183189</a>: D‐mannose versus placebo in patients with a high risk of recurrent UTI (target number: 50) </p> </li> <li> <p><a href="./references#CD013608-bbs2-0016" title="HellemannM . Effects of a food for special medical purposes containing d-mannose, birch extract, vitamin D and vitamin A for the dietary management of acute symptomatic uncomplicated urinary tract infections in females - a randomized, double-blind, placebo-controlled, parallel-design study. www.trialsearch.who.int/Trial2.aspx?TrialID=DRKS00013240 (first received 11 June 2017). [CENTRAL: CN-01890405] ">DRKS00013240</a>: D‐mannose plus herbal extracts versus herbal extracts for the dietary management of acute symptomatic uncomplicated UTIs in females (target number: 100) </p> </li> <li> <p><a href="./references#CD013608-bbs2-0017" title="FranssenM , CookJ , RobinsonJ , WilliamsN , GlogowskaM , YangY , et al. D-MannosE to prevent Recurrent urinary tract InfecTions (MERIT): protocol for a randomised controlled trial. BMJ Open2021;11(1):e037128. [MEDLINE: 33441350]">MERIT 2021</a>: D‐mannose versus placebo to prevent recurrent UTIs in women (target number: 598) </p> </li> <li> <p><a href="./references#CD013608-bbs2-0018" title="D'AnnaR . Nutritional supplementation for recurrent urinary tract infections in women [Nutritional supplementation for extending time between recurrent urinary tract infections in women: a randomized double blind cross-over trial]. www.clinicaltrials.gov/show/NCT03597152 (first received 24 July 2018). ">NCT03597152</a>: Nutritional supplementation with D‐mannose versus placebo for recurrent UTIs in women (target number: 250) </p> </li> <li> <p><a href="./references#CD013608-bbs2-0019" title="FlachJ . Winclove CLEAR for recurrent urinary tract infections in women [A randomized, placebo-controlled, pilot study to evaluate the effects winclove CLEAR in female recurrent urinary tract infection patients]. www.trialregister.nl/trial/6832 (first received 25 January 2018). ">PROTON 2018</a>: Winclove CLEAR versus placebo in females with recurrent UTI (target number: 40). </p> </li> </ul> </p> </section> </section> </section> <section id="CD013608-sec-0052"> <h3 class="title">Risk of bias in included studies</h3> <p>See the 'Risk of Bias' section under <a href="./references#CD013608-sec-0111" title="">Characteristics of included studies</a> tables for a detailed assessment of bias within each included study. </p> <p>See <a href="#CD013608-fig-0002">Figure 2</a> for a graphical summary of the assessment of bias within each included study. </p> <div class="figure" id="CD013608-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD013608-fig-0002" src="/cdsr/doi/10.1002/14651858.CD013608.pub2/media/CDSR/CD013608/image_n/nCD013608-FIG-02.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <p>The majority of studies were characterised by an unclear or high risk of bias across most domains. This was largely due to a lack of detail provided for concealing allocation, open‐label study design, selective reporting, and funding declarations (pharmaceutical or lack of information). Using funnel plots to detect publication bias was not feasible due to the small number of studies. </p> <section id="CD013608-sec-0053"> <h4 class="title">Allocation</h4> <section id="CD013608-sec-0054"> <h5 class="title">Random sequence generation</h5> <p>Four studies were judged to have unclear risk of bias (<a href="./references#CD013608-bbs2-0001" title="De LeoV , CappelliV , MassaroMG , TostiC , MorganteG . Evaluation of the effects of a natural dietary supplement with cranberry, Noxamicina ® and D-mannose in recurrent urinary infections in perimenopausal women. Minerva Ginecologica2017;69(4):336-41. [MEDLINE: 28608666]">De Leo 2017</a>; <a href="./references#CD013608-bbs2-0003" title="KuzmenkoAV , KuzmenkoVV , GyaurgievTA . Efficacy of combined antibacterial-prebiotic therapy in combination with D-mannose in women with uncomplicated lower urinary tract infection. Urologiia2019;(6):38-43. [MEDLINE: 32003165]">Kuzmenko 2019</a>; <a href="./references#CD013608-bbs2-0004" title="Lopes De CarvalhoL , FrancavillaG , MottaR , BrichettoG . D-mannose, cranberry and Vitamin C are effective in preventing urinary tract infections in multiple sclerosis subjects [abstract no: 108]. Multiple Sclerosis2012;18(5):S12-3. [EMBASE: 70762266]">Lopes de Carvalho 2012</a>; <a href="./references#CD013608-bbs2-0006" title="PorruD , ParmigianiA , TinelliC , BarlettaD , ChoussosD , Di FrancoC , et al. Oral D-mannose in recurrent urinary tract infections in women: a pilot study. Journal of Clinical Urology2014;7(3):208-13. [EMBASE: 372993100]">Porru 2014</a>). These four studies were reported to be a 'randomised' controlled trial or having 'randomly assigned participants' to treatment groups; however, the methods that were used to carry out the randomisation process were not described in any further or sufficient detail. </p> <p>Three studies were judged to be at low risk of bias (<a href="./references#CD013608-bbs2-0002" title="AltaracS , PapesD . Use of D-mannose in prophylaxis of recurrent urinary tract infections (UTIs) in women. BJU International2014;113(1):9-10. [MEDLINE: 24215164]KranjcecB , PapesD , AltaracS . D-mannose powder for prophylaxis of recurrent urinary tract infections in women: a randomized clinical trial. World Journal of Urology2014;32(1):79-84. [MEDLINE: 23633128]">Kranjcec 2014</a>; <a href="./references#CD013608-bbs2-0005" title="PalleschiG , CarboneA , ZanelloPP , MeleR , LetoA , FuschiA , et al. Prospective study to compare antibiosis versus the association of N-acetylcysteine, D-mannose and Morinda citrifolia fruit extract in preventing urinary tract infections in patients submitted to urodynamic investigation. Archivio Italiano di Urologia, Andrologia2017;89(1):45-50. [MEDLINE: 28403598]">Palleschi 2017</a>; <a href="./references#CD013608-bbs2-0007" title="RussoE , Montt GuevaraM , GianniniA , MannellaP , PallaG , CarettoM , et al. Cranberry, D-mannose and anti-inflammatory agents prevent lower urinary tract symptoms in women undergoing prolapse surgery. Climacteric2019;23(2):201-5. [MEDLINE: 31674202]">Russo 2019</a>). These three studies described adequate details of the methods that were used to carry out the randomisation process (rolling a dice, statistical series based on random sampling, or a uniform allocation ratio (1:1)). </p> </section> <section id="CD013608-sec-0055"> <h5 class="title">Allocation concealment</h5> <p>Three open‐label studies were judged to be at high risk of bias (<a href="./references#CD013608-bbs2-0001" title="De LeoV , CappelliV , MassaroMG , TostiC , MorganteG . Evaluation of the effects of a natural dietary supplement with cranberry, Noxamicina ® and D-mannose in recurrent urinary infections in perimenopausal women. Minerva Ginecologica2017;69(4):336-41. [MEDLINE: 28608666]">De Leo 2017</a>; <a href="./references#CD013608-bbs2-0002" title="AltaracS , PapesD . Use of D-mannose in prophylaxis of recurrent urinary tract infections (UTIs) in women. BJU International2014;113(1):9-10. [MEDLINE: 24215164]KranjcecB , PapesD , AltaracS . D-mannose powder for prophylaxis of recurrent urinary tract infections in women: a randomized clinical trial. World Journal of Urology2014;32(1):79-84. [MEDLINE: 23633128]">Kranjcec 2014</a>; <a href="./references#CD013608-bbs2-0003" title="KuzmenkoAV , KuzmenkoVV , GyaurgievTA . Efficacy of combined antibacterial-prebiotic therapy in combination with D-mannose in women with uncomplicated lower urinary tract infection. Urologiia2019;(6):38-43. [MEDLINE: 32003165]">Kuzmenko 2019</a>). The remaining four studies did not provide any information concerning allocation concealment and were judged to have unclear risk of bias. </p> </section> </section> <section id="CD013608-sec-0056"> <h4 class="title">Blinding</h4> <section id="CD013608-sec-0057"> <h5 class="title">Blinding of participants and personnel</h5> <p>Six studies were judged to be at high risk of bias (<a href="./references#CD013608-bbs2-0001" title="De LeoV , CappelliV , MassaroMG , TostiC , MorganteG . Evaluation of the effects of a natural dietary supplement with cranberry, Noxamicina ® and D-mannose in recurrent urinary infections in perimenopausal women. Minerva Ginecologica2017;69(4):336-41. [MEDLINE: 28608666]">De Leo 2017</a>; <a href="./references#CD013608-bbs2-0002" title="AltaracS , PapesD . Use of D-mannose in prophylaxis of recurrent urinary tract infections (UTIs) in women. BJU International2014;113(1):9-10. [MEDLINE: 24215164]KranjcecB , PapesD , AltaracS . D-mannose powder for prophylaxis of recurrent urinary tract infections in women: a randomized clinical trial. World Journal of Urology2014;32(1):79-84. [MEDLINE: 23633128]">Kranjcec 2014</a>; <a href="./references#CD013608-bbs2-0003" title="KuzmenkoAV , KuzmenkoVV , GyaurgievTA . Efficacy of combined antibacterial-prebiotic therapy in combination with D-mannose in women with uncomplicated lower urinary tract infection. Urologiia2019;(6):38-43. [MEDLINE: 32003165]">Kuzmenko 2019</a>; <a href="./references#CD013608-bbs2-0005" title="PalleschiG , CarboneA , ZanelloPP , MeleR , LetoA , FuschiA , et al. Prospective study to compare antibiosis versus the association of N-acetylcysteine, D-mannose and Morinda citrifolia fruit extract in preventing urinary tract infections in patients submitted to urodynamic investigation. Archivio Italiano di Urologia, Andrologia2017;89(1):45-50. [MEDLINE: 28403598]">Palleschi 2017</a>; <a href="./references#CD013608-bbs2-0006" title="PorruD , ParmigianiA , TinelliC , BarlettaD , ChoussosD , Di FrancoC , et al. Oral D-mannose in recurrent urinary tract infections in women: a pilot study. Journal of Clinical Urology2014;7(3):208-13. [EMBASE: 372993100]">Porru 2014</a>; <a href="./references#CD013608-bbs2-0007" title="RussoE , Montt GuevaraM , GianniniA , MannellaP , PallaG , CarettoM , et al. Cranberry, D-mannose and anti-inflammatory agents prevent lower urinary tract symptoms in women undergoing prolapse surgery. Climacteric2019;23(2):201-5. [MEDLINE: 31674202]">Russo 2019</a>). All were all open‐label studies and did not blind anyone. </p> <p>One study was judged to have unclear risk of bias. <a href="./references#CD013608-bbs2-0004" title="Lopes De CarvalhoL , FrancavillaG , MottaR , BrichettoG . D-mannose, cranberry and Vitamin C are effective in preventing urinary tract infections in multiple sclerosis subjects [abstract no: 108]. Multiple Sclerosis2012;18(5):S12-3. [EMBASE: 70762266]">Lopes de Carvalho 2012</a> reported that the examining physician and subjects were blinded to the procedure; however, the study states to be blinded, but insufficient details were available. </p> </section> <section id="CD013608-sec-0058"> <h5 class="title">Blinding of outcome assessors</h5> <p>All seven studies were judged to be at high risk of bias. Six studies were open‐label.</p> </section> </section> <section id="CD013608-sec-0059"> <h4 class="title">Incomplete outcome data</h4> <p>Four studies did not provide sufficient information and were judged to have unclear risk of bias (<a href="./references#CD013608-bbs2-0001" title="De LeoV , CappelliV , MassaroMG , TostiC , MorganteG . Evaluation of the effects of a natural dietary supplement with cranberry, Noxamicina ® and D-mannose in recurrent urinary infections in perimenopausal women. Minerva Ginecologica2017;69(4):336-41. [MEDLINE: 28608666]">De Leo 2017</a>; <a href="./references#CD013608-bbs2-0003" title="KuzmenkoAV , KuzmenkoVV , GyaurgievTA . Efficacy of combined antibacterial-prebiotic therapy in combination with D-mannose in women with uncomplicated lower urinary tract infection. Urologiia2019;(6):38-43. [MEDLINE: 32003165]">Kuzmenko 2019</a>; <a href="./references#CD013608-bbs2-0004" title="Lopes De CarvalhoL , FrancavillaG , MottaR , BrichettoG . D-mannose, cranberry and Vitamin C are effective in preventing urinary tract infections in multiple sclerosis subjects [abstract no: 108]. Multiple Sclerosis2012;18(5):S12-3. [EMBASE: 70762266]">Lopes de Carvalho 2012</a>; <a href="./references#CD013608-bbs2-0006" title="PorruD , ParmigianiA , TinelliC , BarlettaD , ChoussosD , Di FrancoC , et al. Oral D-mannose in recurrent urinary tract infections in women: a pilot study. Journal of Clinical Urology2014;7(3):208-13. [EMBASE: 372993100]">Porru 2014</a>. </p> <p>Three studies were judged to be at low risk of bias. All participants were accounted for from the start to the end of the study, and attrition rates were low (0% to 6.25%) (<a href="./references#CD013608-bbs2-0002" title="AltaracS , PapesD . Use of D-mannose in prophylaxis of recurrent urinary tract infections (UTIs) in women. BJU International2014;113(1):9-10. [MEDLINE: 24215164]KranjcecB , PapesD , AltaracS . D-mannose powder for prophylaxis of recurrent urinary tract infections in women: a randomized clinical trial. World Journal of Urology2014;32(1):79-84. [MEDLINE: 23633128]">Kranjcec 2014</a>; <a href="./references#CD013608-bbs2-0005" title="PalleschiG , CarboneA , ZanelloPP , MeleR , LetoA , FuschiA , et al. Prospective study to compare antibiosis versus the association of N-acetylcysteine, D-mannose and Morinda citrifolia fruit extract in preventing urinary tract infections in patients submitted to urodynamic investigation. Archivio Italiano di Urologia, Andrologia2017;89(1):45-50. [MEDLINE: 28403598]">Palleschi 2017</a>; <a href="./references#CD013608-bbs2-0007" title="RussoE , Montt GuevaraM , GianniniA , MannellaP , PallaG , CarettoM , et al. Cranberry, D-mannose and anti-inflammatory agents prevent lower urinary tract symptoms in women undergoing prolapse surgery. Climacteric2019;23(2):201-5. [MEDLINE: 31674202]">Russo 2019</a>). </p> </section> <section id="CD013608-sec-0060"> <h4 class="title">Selective reporting</h4> <p>Six studies did not provide trial registration numbers or details to an a priori‐published protocol and were judged to have unclear risk of bias. </p> <p><a href="./references#CD013608-bbs2-0006" title="PorruD , ParmigianiA , TinelliC , BarlettaD , ChoussosD , Di FrancoC , et al. Oral D-mannose in recurrent urinary tract infections in women: a pilot study. Journal of Clinical Urology2014;7(3):208-13. [EMBASE: 372993100]">Porru 2014</a> provided trial registration numbers and was judged to be at low risk of bias. The methodology, including outcomes planned, matched the study registration details. </p> </section> <section id="CD013608-sec-0061"> <h4 class="title">Other potential sources of bias</h4> <section id="CD013608-sec-0062"> <h5 class="title">Sources of funding and conflicts of interest</h5> <p><a href="./references#CD013608-bbs2-0007" title="RussoE , Montt GuevaraM , GianniniA , MannellaP , PallaG , CarettoM , et al. Cranberry, D-mannose and anti-inflammatory agents prevent lower urinary tract symptoms in women undergoing prolapse surgery. Climacteric2019;23(2):201-5. [MEDLINE: 31674202]">Russo 2019</a> declared funding from pharmaceutical industry sources and was judged to be at high risk of bias. </p> <p>Three studies did not declare any information regarding their funding sources and were judged to have unclear risk of other bias (<a href="./references#CD013608-bbs2-0001" title="De LeoV , CappelliV , MassaroMG , TostiC , MorganteG . Evaluation of the effects of a natural dietary supplement with cranberry, Noxamicina ® and D-mannose in recurrent urinary infections in perimenopausal women. Minerva Ginecologica2017;69(4):336-41. [MEDLINE: 28608666]">De Leo 2017</a>; <a href="./references#CD013608-bbs2-0003" title="KuzmenkoAV , KuzmenkoVV , GyaurgievTA . Efficacy of combined antibacterial-prebiotic therapy in combination with D-mannose in women with uncomplicated lower urinary tract infection. Urologiia2019;(6):38-43. [MEDLINE: 32003165]">Kuzmenko 2019</a>; <a href="./references#CD013608-bbs2-0005" title="PalleschiG , CarboneA , ZanelloPP , MeleR , LetoA , FuschiA , et al. Prospective study to compare antibiosis versus the association of N-acetylcysteine, D-mannose and Morinda citrifolia fruit extract in preventing urinary tract infections in patients submitted to urodynamic investigation. Archivio Italiano di Urologia, Andrologia2017;89(1):45-50. [MEDLINE: 28403598]">Palleschi 2017</a>. </p> <p>Four studies did not declare whether the authors had any conflicts of interest (<a href="./references#CD013608-bbs2-0001" title="De LeoV , CappelliV , MassaroMG , TostiC , MorganteG . Evaluation of the effects of a natural dietary supplement with cranberry, Noxamicina ® and D-mannose in recurrent urinary infections in perimenopausal women. Minerva Ginecologica2017;69(4):336-41. [MEDLINE: 28608666]">De Leo 2017</a>; <a href="./references#CD013608-bbs2-0003" title="KuzmenkoAV , KuzmenkoVV , GyaurgievTA . Efficacy of combined antibacterial-prebiotic therapy in combination with D-mannose in women with uncomplicated lower urinary tract infection. Urologiia2019;(6):38-43. [MEDLINE: 32003165]">Kuzmenko 2019</a>; <a href="./references#CD013608-bbs2-0004" title="Lopes De CarvalhoL , FrancavillaG , MottaR , BrichettoG . D-mannose, cranberry and Vitamin C are effective in preventing urinary tract infections in multiple sclerosis subjects [abstract no: 108]. Multiple Sclerosis2012;18(5):S12-3. [EMBASE: 70762266]">Lopes de Carvalho 2012</a>; <a href="./references#CD013608-bbs2-0005" title="PalleschiG , CarboneA , ZanelloPP , MeleR , LetoA , FuschiA , et al. Prospective study to compare antibiosis versus the association of N-acetylcysteine, D-mannose and Morinda citrifolia fruit extract in preventing urinary tract infections in patients submitted to urodynamic investigation. Archivio Italiano di Urologia, Andrologia2017;89(1):45-50. [MEDLINE: 28403598]">Palleschi 2017</a>). <a href="./references#CD013608-bbs2-0002" title="AltaracS , PapesD . Use of D-mannose in prophylaxis of recurrent urinary tract infections (UTIs) in women. BJU International2014;113(1):9-10. [MEDLINE: 24215164]KranjcecB , PapesD , AltaracS . D-mannose powder for prophylaxis of recurrent urinary tract infections in women: a randomized clinical trial. World Journal of Urology2014;32(1):79-84. [MEDLINE: 23633128]">Kranjcec 2014</a> and <a href="./references#CD013608-bbs2-0007" title="RussoE , Montt GuevaraM , GianniniA , MannellaP , PallaG , CarettoM , et al. Cranberry, D-mannose and anti-inflammatory agents prevent lower urinary tract symptoms in women undergoing prolapse surgery. Climacteric2019;23(2):201-5. [MEDLINE: 31674202]">Russo 2019</a> declared that their authors had no conflicts of interest; however, their funding sources were not reported. </p> <p><a href="./references#CD013608-bbs2-0006" title="PorruD , ParmigianiA , TinelliC , BarlettaD , ChoussosD , Di FrancoC , et al. Oral D-mannose in recurrent urinary tract infections in women: a pilot study. Journal of Clinical Urology2014;7(3):208-13. [EMBASE: 372993100]">Porru 2014</a> declared that no funding was received from any commercial source and declared that the authors did not have any conflicts of interest and was judged to be at low risk of bias. </p> <p>No other potential sources of bias were identified.</p> </section> </section> </section> <section id="CD013608-sec-0063"> <h3 class="title" id="CD013608-sec-0063">Effects of interventions</h3> <p>See: <a href="./full#CD013608-tbl-0001"><b>Summary of findings 1</b> D‐mannose (2 g) versus no treatment for preventing or treating urinary tract infections</a>; <a href="./full#CD013608-tbl-0002"><b>Summary of findings 2</b> D‐mannose (2 g) versus nitrofurantoin (50 mg) for preventing or treating urinary tract infections</a> </p> <section id="CD013608-sec-0064"> <h4 class="title">D‐mannose versus no treatment</h4> <p><a href="./references#CD013608-bbs2-0002" title="AltaracS , PapesD . Use of D-mannose in prophylaxis of recurrent urinary tract infections (UTIs) in women. BJU International2014;113(1):9-10. [MEDLINE: 24215164]KranjcecB , PapesD , AltaracS . D-mannose powder for prophylaxis of recurrent urinary tract infections in women: a randomized clinical trial. World Journal of Urology2014;32(1):79-84. [MEDLINE: 23633128]">Kranjcec 2014</a> compared D‐mannose (2 g oral powder in 200 mL water) once/day to no treatment in 205 women who have acute or recurrent cystitis over a 24‐week period (prevention and treatment study). </p> <section id="CD013608-sec-0065"> <h5 class="title">Symptomatic and bacteriuria‐confirmed UTI</h5> <p><a href="./references#CD013608-bbs2-0002" title="AltaracS , PapesD . Use of D-mannose in prophylaxis of recurrent urinary tract infections (UTIs) in women. BJU International2014;113(1):9-10. [MEDLINE: 24215164]KranjcecB , PapesD , AltaracS . D-mannose powder for prophylaxis of recurrent urinary tract infections in women: a randomized clinical trial. World Journal of Urology2014;32(1):79-84. [MEDLINE: 23633128]">Kranjcec 2014</a> reported D‐mannose reduced the number of symptomatic and bacteriuria‐confirmed UTIs (<a href="./references#CD013608-fig-0003" title="">Analysis 1.1</a> (1 study, 205 participants): RR 0.24, 95% IC 0.15 to 0.39; very low certainty evidence). </p> </section> <section id="CD013608-sec-0066"> <h5 class="title">Symptomatic only UTI</h5> <p><a href="./references#CD013608-bbs2-0002" title="AltaracS , PapesD . Use of D-mannose in prophylaxis of recurrent urinary tract infections (UTIs) in women. BJU International2014;113(1):9-10. [MEDLINE: 24215164]KranjcecB , PapesD , AltaracS . D-mannose powder for prophylaxis of recurrent urinary tract infections in women: a randomized clinical trial. World Journal of Urology2014;32(1):79-84. [MEDLINE: 23633128]">Kranjcec 2014</a> reported median days and IQR time from prophylactic therapy start to cystitis symptoms onset: 43 days (IQR: 15 to 50) for D‐mannose (103 participants) and 28 days (IQR: 20 to 42) for no treatment (102 participants) (very low certainty evidence). </p> </section> <section id="CD013608-sec-0067"> <h5 class="title">Adverse events</h5> <p><a href="./references#CD013608-bbs2-0002" title="AltaracS , PapesD . Use of D-mannose in prophylaxis of recurrent urinary tract infections (UTIs) in women. BJU International2014;113(1):9-10. [MEDLINE: 24215164]KranjcecB , PapesD , AltaracS . D-mannose powder for prophylaxis of recurrent urinary tract infections in women: a randomized clinical trial. World Journal of Urology2014;32(1):79-84. [MEDLINE: 23633128]">Kranjcec 2014</a> reported eight adverse events (diarrhoea) in the D‐mannose group and no adverse events in the no treatment group (<a href="./references#CD013608-fig-0004" title="">Analysis 1.2</a> (1 study, 205 participants): RR 16.84, 95% CI 0.98 to 287.92; very low certainty evidence). See <a href="./appendices#CD013608-sec-0102">Appendix 5</a>. </p> </section> <section id="CD013608-sec-0068"> <h5 class="title">Other outcomes</h5> <p>The following outcomes were not reported.</p> <p> <ul id="CD013608-list-0027"> <li> <p>Asymptomatic bacteriuria</p> </li> <li> <p>Changes to previous treatment regimen</p> </li> <li> <p>Pain</p> </li> <li> <p>Cure/complete remission.</p> </li> </ul> </p> </section> </section> <section id="CD013608-sec-0069"> <h4 class="title">D‐mannose versus antibiotics</h4> <p><a href="./references#CD013608-bbs2-0002" title="AltaracS , PapesD . Use of D-mannose in prophylaxis of recurrent urinary tract infections (UTIs) in women. BJU International2014;113(1):9-10. [MEDLINE: 24215164]KranjcecB , PapesD , AltaracS . D-mannose powder for prophylaxis of recurrent urinary tract infections in women: a randomized clinical trial. World Journal of Urology2014;32(1):79-84. [MEDLINE: 23633128]">Kranjcec 2014</a> compared oral D‐mannose (2 g powder in 200 mL water once/day) to oral nitrofurantoin (50 mg once/day) in 206 women who had acute or recurrent cystitis over a 24‐week period (prevention and treatment study). </p> <p><a href="./references#CD013608-bbs2-0006" title="PorruD , ParmigianiA , TinelliC , BarlettaD , ChoussosD , Di FrancoC , et al. Oral D-mannose in recurrent urinary tract infections in women: a pilot study. Journal of Clinical Urology2014;7(3):208-13. [EMBASE: 372993100]">Porru 2014</a> compared oral D‐mannose (3 g tablets/day for 2 weeks, reduced to 2 g/day for 22 weeks) to oral trimethoprim/sulfamethoxazole (160/800 mg twice/day, followed by a single dose at bedtime for 1 week each month in the following 22 weeks), in 120 females who have acute or recurrent symptomatic UTI, over a 24‐week period (prevention and treatment study). <a href="./references#CD013608-bbs2-0006" title="PorruD , ParmigianiA , TinelliC , BarlettaD , ChoussosD , Di FrancoC , et al. Oral D-mannose in recurrent urinary tract infections in women: a pilot study. Journal of Clinical Urology2014;7(3):208-13. [EMBASE: 372993100]">Porru 2014</a> was a cross‐over study with no washout period and no available data from the first phase and was therefore not included in our meta‐analyses (see <a href="./appendices#CD013608-sec-0101">Appendix 4</a>). </p> <section id="CD013608-sec-0070"> <h5 class="title">Symptomatic and bacteriuria‐confirmed UTI</h5> <p><a href="./references#CD013608-bbs2-0002" title="AltaracS , PapesD . Use of D-mannose in prophylaxis of recurrent urinary tract infections (UTIs) in women. BJU International2014;113(1):9-10. [MEDLINE: 24215164]KranjcecB , PapesD , AltaracS . D-mannose powder for prophylaxis of recurrent urinary tract infections in women: a randomized clinical trial. World Journal of Urology2014;32(1):79-84. [MEDLINE: 23633128]">Kranjcec 2014</a> reported no difference between D‐mannose and nitrofurantoin on symptomatic and bacteriuria‐confirmed UTIs (<a href="./references#CD013608-fig-0005" title="">Analysis 2.1</a> (1 study, 206 participants): RR 0.71, 95% CI 0.39 to 1.31; very low certainty evidence). </p> </section> <section id="CD013608-sec-0071"> <h5 class="title">Symptomatic only UTI</h5> <p><a href="./references#CD013608-bbs2-0002" title="AltaracS , PapesD . Use of D-mannose in prophylaxis of recurrent urinary tract infections (UTIs) in women. BJU International2014;113(1):9-10. [MEDLINE: 24215164]KranjcecB , PapesD , AltaracS . D-mannose powder for prophylaxis of recurrent urinary tract infections in women: a randomized clinical trial. World Journal of Urology2014;32(1):79-84. [MEDLINE: 23633128]">Kranjcec 2014</a> reported median days and IQR from prophylactic therapy start to cystitis symptoms onset: 43 days (15 to 50) for D‐mannose (103 participants) and 24 days (15 to 50) for nitrofurantoin (103 participants) (very low certainty evidence). </p> </section> <section id="CD013608-sec-0072"> <h5 class="title">Adverse events</h5> <p><a href="./references#CD013608-bbs2-0002" title="AltaracS , PapesD . Use of D-mannose in prophylaxis of recurrent urinary tract infections (UTIs) in women. BJU International2014;113(1):9-10. [MEDLINE: 24215164]KranjcecB , PapesD , AltaracS . D-mannose powder for prophylaxis of recurrent urinary tract infections in women: a randomized clinical trial. World Journal of Urology2014;32(1):79-84. [MEDLINE: 23633128]">Kranjcec 2014</a> reported eight adverse events (diarrhoea) in the D‐mannose group and 29 adverse events (diarrhoea, nausea, headache, skin rash, vaginal burning) in the nitrofurantoin group (<a href="./references#CD013608-fig-0006" title="">Analysis 2.2</a> (1 study, 206 participants): RR 0.28, 95% CI 0.13 to 0.57; very low certainty evidence). See <a href="./appendices#CD013608-sec-0102">Appendix 5</a>. </p> </section> <section id="CD013608-sec-0073"> <h5 class="title">Other outcomes</h5> <p>The following outcomes were not reported.</p> <p> <ul id="CD013608-list-0028"> <li> <p>Asymptomatic bacteriuria</p> </li> <li> <p>Changes to previous treatment regimen</p> </li> <li> <p>Pain</p> </li> <li> <p>Cure/complete remission.</p> </li> </ul> </p> </section> </section> <section id="CD013608-sec-0074"> <h4 class="title">D‐mannose plus supplements versus placebo or no treatment</h4> <p><a href="./references#CD013608-bbs2-0001" title="De LeoV , CappelliV , MassaroMG , TostiC , MorganteG . Evaluation of the effects of a natural dietary supplement with cranberry, Noxamicina ® and D-mannose in recurrent urinary infections in perimenopausal women. Minerva Ginecologica2017;69(4):336-41. [MEDLINE: 28608666]">De Leo 2017</a> compared a formulation of D‐mannose plus cranberry plus noxamicina (unknown doses, one oral sachet/day) for the first 10 days of the month to no treatment in 150 participants who have recurrent episodes of cystitis over a 12‐week period (prevention and treatment study). </p> <p><a href="./references#CD013608-bbs2-0004" title="Lopes De CarvalhoL , FrancavillaG , MottaR , BrichettoG . D-mannose, cranberry and Vitamin C are effective in preventing urinary tract infections in multiple sclerosis subjects [abstract no: 108]. Multiple Sclerosis2012;18(5):S12-3. [EMBASE: 70762266]">Lopes de Carvalho 2012</a> compared D‐mannose (100 mg) plus cranberry (40 mg) plus vitamin C (60 mg) (2 doses/day) for 90 days to placebo in 21 females and males who have multiple sclerosis over a 12‐week period (prevention and treatment study). </p> <p><a href="./references#CD013608-bbs2-0007" title="RussoE , Montt GuevaraM , GianniniA , MannellaP , PallaG , CarettoM , et al. Cranberry, D-mannose and anti-inflammatory agents prevent lower urinary tract symptoms in women undergoing prolapse surgery. Climacteric2019;23(2):201-5. [MEDLINE: 31674202]">Russo 2019</a> compared a formulation of D‐mannose plus cranberry plus Boswellia plus Curcuma plus NoxamicineVR (Kistinox ActVR) oral preparation (doses not reported, 2 doses/day) as a nutritional supplement for two weeks after surgery to no treatment in 40 postmenopausal women who were submitted to native tissue repair to cystocele from symptomatic isolate anterior prolapse stage three or higher, over a four‐week postoperative period (prevention study). </p> <p>Due to the lack of data on similar outcomes, no meta‐analysis was possible.</p> <section id="CD013608-sec-0075"> <h5 class="title">Symptomatic and bacteriuria confirmed UTI</h5> <p><a href="./references#CD013608-bbs2-0004" title="Lopes De CarvalhoL , FrancavillaG , MottaR , BrichettoG . D-mannose, cranberry and Vitamin C are effective in preventing urinary tract infections in multiple sclerosis subjects [abstract no: 108]. Multiple Sclerosis2012;18(5):S12-3. [EMBASE: 70762266]">Lopes de Carvalho 2012</a> reported D‐mannose plus cranberry and vitamin C had a "significant reduction in the number of UTIs" compared to placebo (1 study, 21 participants; very low certainty evidence). </p> <p><a href="./references#CD013608-bbs2-0007" title="RussoE , Montt GuevaraM , GianniniA , MannellaP , PallaG , CarettoM , et al. Cranberry, D-mannose and anti-inflammatory agents prevent lower urinary tract symptoms in women undergoing prolapse surgery. Climacteric2019;23(2):201-5. [MEDLINE: 31674202]">Russo 2019</a> reported 1/20 UTI infections with D‐mannose plus cranberry, Boswellia, Curcuma and NoxamicineVR (Kistinox ActVR) (unknown doses) and 1/20 UTI infections with placebo (<a href="./references#CD013608-fig-0007" title="">Analysis 3.1</a>: 1 study, 40 participants; very low certainty evidence). </p> </section> <section id="CD013608-sec-0076"> <h5 class="title">Symptomatic only UTI</h5> <p><a href="./references#CD013608-bbs2-0001" title="De LeoV , CappelliV , MassaroMG , TostiC , MorganteG . Evaluation of the effects of a natural dietary supplement with cranberry, Noxamicina ® and D-mannose in recurrent urinary infections in perimenopausal women. Minerva Ginecologica2017;69(4):336-41. [MEDLINE: 28608666]">De Leo 2017</a> reported a slight decrease in symptomatic cystitis at three months for D‐mannose plus cranberry plus noxamicina (unknown doses) compared to no treatment (<a href="./references#CD013608-fig-0008" title="">Analysis 3.2</a>: 1 study, 150 participants; very low certainty evidence). </p> </section> <section id="CD013608-sec-0077"> <h5 class="title">Pain</h5> <p><a href="./references#CD013608-bbs2-0007" title="RussoE , Montt GuevaraM , GianniniA , MannellaP , PallaG , CarettoM , et al. Cranberry, D-mannose and anti-inflammatory agents prevent lower urinary tract symptoms in women undergoing prolapse surgery. Climacteric2019;23(2):201-5. [MEDLINE: 31674202]">Russo 2019</a> reported mean pain on a VAS (scale numbers are not reported, assumed 1 ‐ 10) was (mean ± SD): 1.2 ± 1.1, n = 20 for the D‐mannose formulation and 1.3 ± 0.9, n = 20 for no treatment (<a href="./references#CD013608-fig-0009" title="">Analysis 3.3</a>: 1 study, 40 participants; very low certainty evidence). </p> </section> <section id="CD013608-sec-0078"> <h5 class="title">Cure/complete remission of symptomatic and a symptomatic UTI</h5> <p><a href="./references#CD013608-bbs2-0001" title="De LeoV , CappelliV , MassaroMG , TostiC , MorganteG . Evaluation of the effects of a natural dietary supplement with cranberry, Noxamicina ® and D-mannose in recurrent urinary infections in perimenopausal women. Minerva Ginecologica2017;69(4):336-41. [MEDLINE: 28608666]">De Leo 2017</a> reported "complete remission of symptoms in 92 women overall" but did not stipulate from which intervention arm these results derive (1 study, 150 participants, very low certainty evidence). </p> </section> <section id="CD013608-sec-0079"> <h5 class="title">Adverse events</h5> <p><a href="./references#CD013608-bbs2-0001" title="De LeoV , CappelliV , MassaroMG , TostiC , MorganteG . Evaluation of the effects of a natural dietary supplement with cranberry, Noxamicina ® and D-mannose in recurrent urinary infections in perimenopausal women. Minerva Ginecologica2017;69(4):336-41. [MEDLINE: 28608666]">De Leo 2017</a>, <a href="./references#CD013608-bbs2-0004" title="Lopes De CarvalhoL , FrancavillaG , MottaR , BrichettoG . D-mannose, cranberry and Vitamin C are effective in preventing urinary tract infections in multiple sclerosis subjects [abstract no: 108]. Multiple Sclerosis2012;18(5):S12-3. [EMBASE: 70762266]">Lopes de Carvalho 2012</a> and <a href="./references#CD013608-bbs2-0007" title="RussoE , Montt GuevaraM , GianniniA , MannellaP , PallaG , CarettoM , et al. Cranberry, D-mannose and anti-inflammatory agents prevent lower urinary tract symptoms in women undergoing prolapse surgery. Climacteric2019;23(2):201-5. [MEDLINE: 31674202]">Russo 2019</a> reported none of the included participants recorded any adverse events (3 studies, 211 participants; very low certainty evidence). See <a href="./appendices#CD013608-sec-0102">Appendix 5</a>. </p> </section> </section> <section id="CD013608-sec-0080"> <h4 class="title">D‐mannose plus supplements versus antibiotics</h4> <p><a href="./references#CD013608-bbs2-0005" title="PalleschiG , CarboneA , ZanelloPP , MeleR , LetoA , FuschiA , et al. Prospective study to compare antibiosis versus the association of N-acetylcysteine, D-mannose and Morinda citrifolia fruit extract in preventing urinary tract infections in patients submitted to urodynamic investigation. Archivio Italiano di Urologia, Andrologia2017;89(1):45-50. [MEDLINE: 28403598]">Palleschi 2017</a> compared D‐mannose (500 mg) plus N‐acetylcysteine (100 mg) plus Morinda citrifolia fruit extract (300 mg)  as 2 vials/day to prulifloxacin (antibiotic) 400 mg/day, in 75 females and males who submitted to mini‐invasive urological diagnostic procedures, over a 15‐day period (prevention study). </p> <section id="CD013608-sec-0081"> <h5 class="title">Symptomatic and bacteriuria confirmed UTI</h5> <p><a href="./references#CD013608-bbs2-0005" title="PalleschiG , CarboneA , ZanelloPP , MeleR , LetoA , FuschiA , et al. Prospective study to compare antibiosis versus the association of N-acetylcysteine, D-mannose and Morinda citrifolia fruit extract in preventing urinary tract infections in patients submitted to urodynamic investigation. Archivio Italiano di Urologia, Andrologia2017;89(1):45-50. [MEDLINE: 28403598]">Palleschi 2017</a> reported 2/37 symptomatic and culture‐positive UTIs with the D‐mannose formulation and 3/38 for prulifloxacin 400 mg (<a href="./references#CD013608-fig-0010" title="">Analysis 4.1</a>: 1 study, 75 participants; very low certainty evidence). </p> </section> <section id="CD013608-sec-0082"> <h5 class="title">Adverse events</h5> <p><a href="./references#CD013608-bbs2-0005" title="PalleschiG , CarboneA , ZanelloPP , MeleR , LetoA , FuschiA , et al. Prospective study to compare antibiosis versus the association of N-acetylcysteine, D-mannose and Morinda citrifolia fruit extract in preventing urinary tract infections in patients submitted to urodynamic investigation. Archivio Italiano di Urologia, Andrologia2017;89(1):45-50. [MEDLINE: 28403598]">Palleschi 2017</a> reported zero adverse events across both treatment arms (1 study, 75 participants; very low certainty evidence). See <a href="./appendices#CD013608-sec-0102">Appendix 5</a>. </p> <p>No data were reported on our remaining primary and secondary outcomes.</p> </section> </section> <section id="CD013608-sec-0083"> <h4 class="title">D‐mannose plus antibiotics and supplements versus antibiotics plus supplements</h4> <p><a href="./references#CD013608-bbs2-0003" title="KuzmenkoAV , KuzmenkoVV , GyaurgievTA . Efficacy of combined antibacterial-prebiotic therapy in combination with D-mannose in women with uncomplicated lower urinary tract infection. Urologiia2019;(6):38-43. [MEDLINE: 32003165]">Kuzmenko 2019</a> compared D‐mannose (dose unknown) plus inulin (dose unknown) plus E551 (silicon dioxide, dose unknown) plus fosfomycin (3 g, antibiotic) plus prebiotic lactulose (1.5 g) to fosfomycin (3 g, antibiotic) plus prebiotic lactulose (1.5 g) in 60 women with acute uncomplicated cystitis over a 24‐week period (treatment study). </p> <section id="CD013608-sec-0084"> <h5 class="title">Symptomatic only UTI</h5> <p><a href="./references#CD013608-bbs2-0003" title="KuzmenkoAV , KuzmenkoVV , GyaurgievTA . Efficacy of combined antibacterial-prebiotic therapy in combination with D-mannose in women with uncomplicated lower urinary tract infection. Urologiia2019;(6):38-43. [MEDLINE: 32003165]">Kuzmenko 2019</a> reported "relief of dysuric phenomena" in both treatment groups (1 study, 60 participants; very low certainty evidence). </p> </section> <section id="CD013608-sec-0085"> <h5 class="title">Pain</h5> <p><a href="./references#CD013608-bbs2-0003" title="KuzmenkoAV , KuzmenkoVV , GyaurgievTA . Efficacy of combined antibacterial-prebiotic therapy in combination with D-mannose in women with uncomplicated lower urinary tract infection. Urologiia2019;(6):38-43. [MEDLINE: 32003165]">Kuzmenko 2019</a> reported "relief of pain" in both treatment groups (1 study, 60 participants; very low certainty evidence). </p> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD013608-sec-0086" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD013608-sec-0086"></div> <section id="CD013608-sec-0087"> <h3 class="title" id="CD013608-sec-0087">Summary of main results</h3> <p>We included seven RCTs (719 participants) in this review; no studies were comparable (by dose or treatment) to enter into a meta‐analysis. </p> <p>The patient populations varied. All studies were in adults, and four studies were in females only. Studies were a mixture of measuring symptomatic‐only cystitis and/or positive culture‐confirmed bacteriuria. Two studies investigated both the treatment and prevention of UTIs. Two studies investigated the prevention of UTIs in a perioperative setting, and two studies were prevention‐only studies. One study was in adults with multiple sclerosis (no description of the history of UTI). Across all studies, recurrent UTI was defined as recurrent episodes of cystitis with at least one positive urine culture during a six‐month period or two or more episodes over 12 months. </p> <p> <ul id="CD013608-list-0029"> <li> <p>D‐mannose (2 g) compared to no treatment had uncertain effects on symptomatic and bacteriuria‐confirmed UTI (1 study, 205 participants; very low certainty evidence). </p> </li> <li> <p>D‐mannose (2 g) compared to antibiotics (nitrofurantoin 50 mg) had uncertain effects on symptomatic and bacteriuria‐confirmed UTI (1 study, 206 participants; very low certainty evidence). </p> </li> <li> <p>D‐mannose in combination with herbal supplements compared to no treatment has uncertain effects on symptomatic and bacteria‐confirmed UTI and pain (1 study, 40 participants, very low certainty evidence). </p> </li> <li> <p>D‐mannose 500 mg in combination with supplements (N‐acetylcysteine and Morinda citrifolia fruit extract) compared to an antibiotic (prulifloxacin 400 mg) has uncertain effects on symptomatic and bacteriuria‐confirmed UTI (1 study, 75 participants, very low certainty evidence). </p> </li> </ul> </p> <p>Individual studies found no clear results that D‐mannose is more or less effective in preventing or treating UTIs in the participant populations of their own criterion. Adverse events were poorly reported, and of the very few adverse effects reported, none were serious (mostly diarrhoea and vaginal burning). </p> </section> <section id="CD013608-sec-0088"> <h3 class="title" id="CD013608-sec-0088">Overall completeness and applicability of evidence</h3> <p>This review highlights the severe lack of high‐quality RCTs testing the efficacy of D‐mannose for UTIs in any population. </p> <p>Despite UTIs being one of the most common adult infections (affecting 50% of women at least once in their lifetime) and the growing global antimicrobial resistance, we found very few studies that adequately test this alternative treatment. Four major issues around the completeness of the evidence were: </p> <p> <ul id="CD013608-list-0030"> <li> <p>Limited sample size and insufficient power</p> </li> <li> <p>Standardised dosing of D‐mannose and comparator treatments</p> </li> <li> <p>Standardised measuring</p> </li> <li> <p>Reporting of outcomes.</p> </li> </ul> </p> <p>Three major issues around the applicability of evidence were:</p> <p> <ol id="CD013608-list-0031"> <li> <p>Participant criteria in the included studies: whilst adult women experience the most frequent rates of UTIs, it is important to know the efficacy and harms of D‐mannose in males, as well as in people under 18 years because this is a non‐prescription dietary supplement available over the counter in most western countries. </p> </li> <li> <p>Outcome measures varied greatly by scale, unit, time point, definitions, and denominators in each group. Two studies did not provide data for the treatment arm from which they expressed a change in symptoms, and therefore, we could not include these studies in our meta‐analysis. Studies reported either rates of UTI or UTI recurrence in a variety of dichotomous and continuous data. </p> </li> <li> <p>Definitions of UTI varied greatly (recurrence, rate, one or more in a three, six, or 12‐month period). Time points at which the outcomes were measured varied greatly (15 days to six months). Studies mentioned symptomatic cystitis and defined pathologically confirmed UTI as a mixture of 'positive urine cultures'. </p> </li> </ol> </p> <p>We identified significant gaps in the evidence. No two studies were comparable for meta‐analysis due to the different dosing of D‐mannose (500 mg, 1 g, or 3 g titrated down to 2 g) as well as most studies investigated different comparator treatments (placebo, no treatment, antibiotics, herbal supplements). </p> </section> <section id="CD013608-sec-0089"> <h3 class="title" id="CD013608-sec-0089">Quality of the evidence</h3> <p>Overall, the quality of the evidence is poor. Most studies were judged to have unclear or high risk of bias across most domains <a href="#CD013608-fig-0002">Figure 2</a>. Data was sparse and addressed very few of the primary and secondary outcomes. </p> <p>Across all comparisons, GRADE evaluations for all outcomes were judged to be very low certainty evidence. The evidence was downgraded three stages: for very serious limitations in the study design or execution (high risk of bias across all studies) (‐2), and sparse data (single study data and small sample sizes) (‐1) (<a href="./full#CD013608-tbl-0001">summary of findings Table 1</a>, <a href="./full#CD013608-tbl-0002">summary of findings Table 2</a>). </p> <p>Very low certainty evidence implies we are very uncertain about results (not estimable due to lack of data). We have no evidence to support or refute the use of D‐mannose in preventing or treating UTIs, and the findings should be viewed with caution. </p> </section> <section id="CD013608-sec-0090"> <h3 class="title" id="CD013608-sec-0090">Potential biases in the review process</h3> <p>This review was conducted as per the protocol following pre‐specified inclusion criteria and used comprehensive literature searches to find all relevant studies. We do not believe there are any other potential biases in this review process. </p> </section> <section id="CD013608-sec-0091"> <h3 class="title" id="CD013608-sec-0091">Agreements and disagreements with other studies or reviews</h3> <p>One systematic review has recently been published on this topic (<a href="./references#CD013608-bbs2-0029" title="LengerSM , BradleyMS , ThomasDA , BertoletMH , LowderJL , SutcliffeS . D-mannose vs other agents for recurrent urinary tract infection prevention in adult women: a systematic review and meta-analysis. American Journal of Obstetrics &amp; Gynecology2020;223(2):265.e1-265.e13. [MEDLINE: 32497610]">Lenger 2020</a>). The authors report a possible positive effect of D‐mannose for preventing UTIs. However, the findings of our review do not support their assessment due to the lack of available evidence on this topic. The inclusion criteria for <a href="./references#CD013608-bbs2-0029" title="LengerSM , BradleyMS , ThomasDA , BertoletMH , LowderJL , SutcliffeS . D-mannose vs other agents for recurrent urinary tract infection prevention in adult women: a systematic review and meta-analysis. American Journal of Obstetrics &amp; Gynecology2020;223(2):265.e1-265.e13. [MEDLINE: 32497610]">Lenger 2020</a> were restricted to women only, over 18 years, and included observational study designs that were limited to prevention and not treatment. <a href="./references#CD013608-bbs2-0029" title="LengerSM , BradleyMS , ThomasDA , BertoletMH , LowderJL , SutcliffeS . D-mannose vs other agents for recurrent urinary tract infection prevention in adult women: a systematic review and meta-analysis. American Journal of Obstetrics &amp; Gynecology2020;223(2):265.e1-265.e13. [MEDLINE: 32497610]">Lenger 2020</a> included only two of our eight RCTs (<a href="./references#CD013608-bbs2-0002" title="AltaracS , PapesD . Use of D-mannose in prophylaxis of recurrent urinary tract infections (UTIs) in women. BJU International2014;113(1):9-10. [MEDLINE: 24215164]KranjcecB , PapesD , AltaracS . D-mannose powder for prophylaxis of recurrent urinary tract infections in women: a randomized clinical trial. World Journal of Urology2014;32(1):79-84. [MEDLINE: 23633128]">Kranjcec 2014</a>; <a href="./references#CD013608-bbs2-0006" title="PorruD , ParmigianiA , TinelliC , BarlettaD , ChoussosD , Di FrancoC , et al. Oral D-mannose in recurrent urinary tract infections in women: a pilot study. Journal of Clinical Urology2014;7(3):208-13. [EMBASE: 372993100]">Porru 2014</a>). <a href="./references#CD013608-bbs2-0029" title="LengerSM , BradleyMS , ThomasDA , BertoletMH , LowderJL , SutcliffeS . D-mannose vs other agents for recurrent urinary tract infection prevention in adult women: a systematic review and meta-analysis. American Journal of Obstetrics &amp; Gynecology2020;223(2):265.e1-265.e13. [MEDLINE: 32497610]">Lenger 2020</a> combined studies into a meta‐analysis that included different doses of D‐mannose and comparisons arms that were not similar. In our view, this is an overinterpretation of very sparse and poor‐quality data. </p> <p>In contrast to <a href="./references#CD013608-bbs2-0029" title="LengerSM , BradleyMS , ThomasDA , BertoletMH , LowderJL , SutcliffeS . D-mannose vs other agents for recurrent urinary tract infection prevention in adult women: a systematic review and meta-analysis. American Journal of Obstetrics &amp; Gynecology2020;223(2):265.e1-265.e13. [MEDLINE: 32497610]">Lenger 2020</a>, we feel that the assessments made in <a href="./references#CD013608-bbs2-0029" title="LengerSM , BradleyMS , ThomasDA , BertoletMH , LowderJL , SutcliffeS . D-mannose vs other agents for recurrent urinary tract infection prevention in adult women: a systematic review and meta-analysis. American Journal of Obstetrics &amp; Gynecology2020;223(2):265.e1-265.e13. [MEDLINE: 32497610]">Lenger 2020</a> are not appropriate recommendations on the harms and benefits of D‐mannose based on the available evidence (which is lacking in quantity, precision, and quality). We identified six ongoing studies (<a href="./references#CD013608-bbs2-0014" title="SubramanianS . D-mannose for prophylaxis against urinary tract Infection in spinal cord injury [D-mannose for prophylaxis against urinary tract Infection in SCI: pilot randomised control study]. www.anzctr.org.au/ACTRN12616001619437.aspx (first received 23 November 2016). ">ACTRN12616001619437</a>; <a href="./references#CD013608-bbs2-0015" title="PattonV . The effectiveness of D-Mannose in patients with high risk of recurrent urinary tract infections. www.anzctr.org.au/ACTRN12619000183189.aspx (first received 8 February 2019). ">ACTRN12619000183189</a>; <a href="./references#CD013608-bbs2-0016" title="HellemannM . Effects of a food for special medical purposes containing d-mannose, birch extract, vitamin D and vitamin A for the dietary management of acute symptomatic uncomplicated urinary tract infections in females - a randomized, double-blind, placebo-controlled, parallel-design study. www.trialsearch.who.int/Trial2.aspx?TrialID=DRKS00013240 (first received 11 June 2017). [CENTRAL: CN-01890405] ">DRKS00013240</a>; <a href="./references#CD013608-bbs2-0017" title="FranssenM , CookJ , RobinsonJ , WilliamsN , GlogowskaM , YangY , et al. D-MannosE to prevent Recurrent urinary tract InfecTions (MERIT): protocol for a randomised controlled trial. BMJ Open2021;11(1):e037128. [MEDLINE: 33441350]">MERIT 2021</a>; <a href="./references#CD013608-bbs2-0018" title="D'AnnaR . Nutritional supplementation for recurrent urinary tract infections in women [Nutritional supplementation for extending time between recurrent urinary tract infections in women: a randomized double blind cross-over trial]. www.clinicaltrials.gov/show/NCT03597152 (first received 24 July 2018). ">NCT03597152</a>; <a href="./references#CD013608-bbs2-0019" title="FlachJ . Winclove CLEAR for recurrent urinary tract infections in women [A randomized, placebo-controlled, pilot study to evaluate the effects winclove CLEAR in female recurrent urinary tract infection patients]. www.trialregister.nl/trial/6832 (first received 25 January 2018). ">PROTON 2018</a>), which we will assess in a future update of this review. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD013608-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013608.pub2/media/CDSR/CD013608/urn:x-wiley:14651858:media:CD013608:CD013608-FIG-01" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD013608-fig-0001" src="/cdsr/doi/10.1002/14651858.CD013608.pub2/media/CDSR/CD013608/image_n/nCD013608-FIG-01.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013608.pub2/media/CDSR/CD013608/image_t/tCD013608-FIG-01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013608.pub2/full#CD013608-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013608.pub2/media/CDSR/CD013608/image_n/nCD013608-FIG-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013608-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013608.pub2/media/CDSR/CD013608/urn:x-wiley:14651858:media:CD013608:CD013608-FIG-02" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD013608-fig-0002" src="/cdsr/doi/10.1002/14651858.CD013608.pub2/media/CDSR/CD013608/image_n/nCD013608-FIG-02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013608.pub2/media/CDSR/CD013608/image_t/tCD013608-FIG-02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013608.pub2/full#CD013608-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013608.pub2/media/CDSR/CD013608/image_n/nCD013608-FIG-02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013608-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013608.pub2/media/CDSR/CD013608/urn:x-wiley:14651858:media:CD013608:CD013608-CMP-001.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: D‐mannose (2 g) versus no treatment, Outcome 1: Symptomatic and bacteriuria‐confirmed UTI (positive culture) at 24 weeks" data-id="CD013608-fig-0003" src="/cdsr/doi/10.1002/14651858.CD013608.pub2/media/CDSR/CD013608/image_n/nCD013608-CMP-001.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013608.pub2/media/CDSR/CD013608/image_t/tCD013608-CMP-001.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1: D‐mannose (2 g) versus no treatment, Outcome 1: Symptomatic and bacteriuria‐confirmed UTI (positive culture) at 24 weeks </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013608.pub2/references#CD013608-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013608.pub2/media/CDSR/CD013608/image_n/nCD013608-CMP-001.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013608-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013608.pub2/media/CDSR/CD013608/urn:x-wiley:14651858:media:CD013608:CD013608-CMP-001.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: D‐mannose (2 g) versus no treatment, Outcome 2: Adverse events" data-id="CD013608-fig-0004" src="/cdsr/doi/10.1002/14651858.CD013608.pub2/media/CDSR/CD013608/image_n/nCD013608-CMP-001.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013608.pub2/media/CDSR/CD013608/image_t/tCD013608-CMP-001.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1: D‐mannose (2 g) versus no treatment, Outcome 2: Adverse events</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013608.pub2/references#CD013608-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013608.pub2/media/CDSR/CD013608/image_n/nCD013608-CMP-001.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013608-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013608.pub2/media/CDSR/CD013608/urn:x-wiley:14651858:media:CD013608:CD013608-CMP-002.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: D‐mannose (2 g) versus nitrofurantoin (50 mg), Outcome 1: Symptomatic and bacteriuria‐confirmed UTI (positive culture) at 24 weeks" data-id="CD013608-fig-0005" src="/cdsr/doi/10.1002/14651858.CD013608.pub2/media/CDSR/CD013608/image_n/nCD013608-CMP-002.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013608.pub2/media/CDSR/CD013608/image_t/tCD013608-CMP-002.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2: D‐mannose (2 g) versus nitrofurantoin (50 mg), Outcome 1: Symptomatic and bacteriuria‐confirmed UTI (positive culture) at 24 weeks </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013608.pub2/references#CD013608-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013608.pub2/media/CDSR/CD013608/image_n/nCD013608-CMP-002.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013608-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013608.pub2/media/CDSR/CD013608/urn:x-wiley:14651858:media:CD013608:CD013608-CMP-002.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: D‐mannose (2 g) versus nitrofurantoin (50 mg), Outcome 2: Adverse events" data-id="CD013608-fig-0006" src="/cdsr/doi/10.1002/14651858.CD013608.pub2/media/CDSR/CD013608/image_n/nCD013608-CMP-002.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013608.pub2/media/CDSR/CD013608/image_t/tCD013608-CMP-002.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2: D‐mannose (2 g) versus nitrofurantoin (50 mg), Outcome 2: Adverse events</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013608.pub2/references#CD013608-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013608.pub2/media/CDSR/CD013608/image_n/nCD013608-CMP-002.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013608-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013608.pub2/media/CDSR/CD013608/urn:x-wiley:14651858:media:CD013608:CD013608-CMP-003.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: D‐mannose (no dose provided) plus herbal combination versus no treatment, Outcome 1: Symptomatic and bacteriuria‐confirmed UTI (positive culture) at 2 weeks" data-id="CD013608-fig-0007" src="/cdsr/doi/10.1002/14651858.CD013608.pub2/media/CDSR/CD013608/image_n/nCD013608-CMP-003.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013608.pub2/media/CDSR/CD013608/image_t/tCD013608-CMP-003.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3: D‐mannose (no dose provided) plus herbal combination versus no treatment, Outcome 1: Symptomatic and bacteriuria‐confirmed UTI (positive culture) at 2 weeks </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013608.pub2/references#CD013608-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013608.pub2/media/CDSR/CD013608/image_n/nCD013608-CMP-003.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013608-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013608.pub2/media/CDSR/CD013608/urn:x-wiley:14651858:media:CD013608:CD013608-CMP-003.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: D‐mannose (no dose provided) plus herbal combination versus no treatment, Outcome 2: Symptomatic only UTI at 3 months" data-id="CD013608-fig-0008" src="/cdsr/doi/10.1002/14651858.CD013608.pub2/media/CDSR/CD013608/image_n/nCD013608-CMP-003.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013608.pub2/media/CDSR/CD013608/image_t/tCD013608-CMP-003.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3: D‐mannose (no dose provided) plus herbal combination versus no treatment, Outcome 2: Symptomatic only UTI at 3 months </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013608.pub2/references#CD013608-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013608.pub2/media/CDSR/CD013608/image_n/nCD013608-CMP-003.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013608-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013608.pub2/media/CDSR/CD013608/urn:x-wiley:14651858:media:CD013608:CD013608-CMP-003.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: D‐mannose (no dose provided) plus herbal combination versus no treatment, Outcome 3: Pain (mean score (VAS 1‐10)): average/patient (day 1 postop)" data-id="CD013608-fig-0009" src="/cdsr/doi/10.1002/14651858.CD013608.pub2/media/CDSR/CD013608/image_n/nCD013608-CMP-003.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013608.pub2/media/CDSR/CD013608/image_t/tCD013608-CMP-003.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.3</div> <div class="figure-caption"> <p>Comparison 3: D‐mannose (no dose provided) plus herbal combination versus no treatment, Outcome 3: Pain (mean score (VAS 1‐10)): average/patient (day 1 postop) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013608.pub2/references#CD013608-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013608.pub2/media/CDSR/CD013608/image_n/nCD013608-CMP-003.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013608-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013608.pub2/media/CDSR/CD013608/urn:x-wiley:14651858:media:CD013608:CD013608-CMP-004.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: D‐mannose (500 mg) plus N‐acetylcysteine (100 mg) plus Morinda citrifolia fruit extract (300 mg) versus prulifloxacin (400 mg), Outcome 1: Symptomatic and bacteriuria‐confirmed UTI (positive culture) at 15 days" data-id="CD013608-fig-0010" src="/cdsr/doi/10.1002/14651858.CD013608.pub2/media/CDSR/CD013608/image_n/nCD013608-CMP-004.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013608.pub2/media/CDSR/CD013608/image_t/tCD013608-CMP-004.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4: D‐mannose (500 mg) plus N‐acetylcysteine (100 mg) plus Morinda citrifolia fruit extract (300 mg) versus prulifloxacin (400 mg), Outcome 1: Symptomatic and bacteriuria‐confirmed UTI (positive culture) at 15 days </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013608.pub2/references#CD013608-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013608.pub2/media/CDSR/CD013608/image_n/nCD013608-CMP-004.01.svg" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD013608-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">D‐mannose (2 g) versus no treatment for preventing or treating urinary tract infections</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>D‐mannose (2 g) versus no treatment for preventing or treating urinary tract infections</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Patient or population:</b> women with acute cystitis or history of recurrent acute cystitis (preventing and treating) </p> <p><b>Settings:</b> general hospital and general practice </p> <p><b>Intervention:</b> D‐mannose (2 g) </p> <p><b>Comparison:</b> no treatment </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>No. of participants<br/>(RCTs)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Quality of the evidence<br/>(GRADE)</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Assumed risk</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>No treatment</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>D‐mannose<br/>(2 g)</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Symptomatic and bacteriuria confirmed UTI (positive culture)</b> </p> <p><b>Follow‐up at 24 weeks</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>608 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>146 per 1000</p> <p>(91 to 237)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.24</p> <p>(0.15 to 0.39)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>205 (1)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>very low<sup>1</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Symptomatic‐only UTI</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>No data</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>No data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Asymptomatic bacteriuria</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>No data</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>No data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Changes to previous treatment regimen</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>No data</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>No data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Pain</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>No data</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>No data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Cure/complete remission</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>No data</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>No data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse effects</b> </p> <p><b>Follow‐up at 24 weeks</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>No events</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>8/103**</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 16.84</p> <p>(0.98 to 287.92)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>205 (1)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>very low<sup>1</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p>** Event rate derived from the raw data. A 'per thousand' rate is non‐informative in view of the scarcity of evidence and zero events in the control group </p> <p><b>CI:</b> Confidence interval; <b>RR:</b> Risk Ratio; <b>UTI:</b> urinary tract infection </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/><b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/><b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/><b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/><b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>1</sup>Downgraded for very serious limitations in the study design or execution (high risk of bias) (‐2), and sparse data (single study data) (‐1) </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">D‐mannose (2 g) versus no treatment for preventing or treating urinary tract infections</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013608.pub2/full#CD013608-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD013608-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">D‐mannose (2 g) versus nitrofurantoin (50 mg) for preventing or treating urinary tract infections</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>D‐mannose (2 g) versus nitrofurantoin (50 mg) for preventing or treating urinary tract infections</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Patient or population:</b> women with acute cystitis or history of recurrent acute cystitis (preventing and treating) </p> <p><b>Settings:</b> general hospital and general practice </p> <p><b>Intervention:</b> D‐mannose (2 g) </p> <p><b>Comparison:</b> nitrofurantoin (50 mg) </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>No. of participants<br/>(RCTs)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Quality of the evidence<br/>(GRADE)</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Assumed risk</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>nitrofurantoin<br/>(50 mg)</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>D‐mannose<br/>(2 g)</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Symptomatic and bacteriuria‐confirmed UTI (positive culture)</b> </p> <p><b>Follow‐up at 24 weeks</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>204 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>145 per 1000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.71</p> <p>(0.39 to 1.31)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>206 (1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>very low<sup>1</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Symptomatic only UTI</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>No data</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>No data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Asymptomatic bacteriuria</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>No data</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>No data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Changes to previous treatment regimen</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>No data</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>No data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Pain</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>No data</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>No data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Cure/complete remission</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>No data</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>No data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse effects</b> </p> <p><b>Follow‐up at 24 weeks</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>282 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>79 per 1000</p> <p>(37 to 160)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.28</p> <p>(0.13 to 0.57)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>206 (1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>very low<sup>1</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><b>CI:</b> Confidence interval; <b>RR:</b> Risk Ratio; <b>UTI:</b> urinary tract infection </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/><b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/><b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/><b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/><b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>1</sup>Downgraded for very serious limitations in the study design or execution (high risk of bias) (‐2), and sparse data (single study data) (‐1). </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">D‐mannose (2 g) versus nitrofurantoin (50 mg) for preventing or treating urinary tract infections</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013608.pub2/full#CD013608-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD013608-tbl-0003"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">D‐mannose (2 g) versus no treatment</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.1 Symptomatic and bacteriuria‐confirmed UTI (positive culture) at 24 weeks <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.2 Adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">D‐mannose (2 g) versus no treatment</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013608.pub2/references#CD013608-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD013608-tbl-0004"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">D‐mannose (2 g) versus nitrofurantoin (50 mg)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.1 Symptomatic and bacteriuria‐confirmed UTI (positive culture) at 24 weeks <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.2 Adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">D‐mannose (2 g) versus nitrofurantoin (50 mg)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013608.pub2/references#CD013608-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD013608-tbl-0005"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">D‐mannose (no dose provided) plus herbal combination versus no treatment</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.1 Symptomatic and bacteriuria‐confirmed UTI (positive culture) at 2 weeks <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.2 Symptomatic only UTI at 3 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>150</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.70 [‐3.27, ‐2.13]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.3 Pain (mean score (VAS 1‐10)): average/patient (day 1 postop) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">D‐mannose (no dose provided) plus herbal combination versus no treatment</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013608.pub2/references#CD013608-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD013608-tbl-0006"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">D‐mannose (500 mg) plus N‐acetylcysteine (100 mg) plus Morinda citrifolia fruit extract (300 mg) versus prulifloxacin (400 mg)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.1 Symptomatic and bacteriuria‐confirmed UTI (positive culture) at 15 days <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1.1 Females</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1.2 Males</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">D‐mannose (500 mg) plus N‐acetylcysteine (100 mg) plus Morinda citrifolia fruit extract (300 mg) versus prulifloxacin (400 mg)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013608.pub2/references#CD013608-tbl-0006">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD013608.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD013608-note-0015">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD013608-note-0012">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD013608-note-0014">Français</a> </li> <li class="section-language"> <a class="" href="hr#CD013608-note-0011">Hrvatski</a> </li> <li class="section-language"> <a class="" href="ja#CD013608-note-0010">日本語</a> </li> <li class="section-language"> <a class="" href="ko#CD013608-note-0008">한국어</a> </li> <li class="section-language"> <a class="" href="ms#CD013608-note-0009">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="pl#CD013608-note-0013">Polski</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD013608-note-0006">简体中文</a> </li> <li class="section-language"> <a class="" href="zh_HANT#CD013608-note-0007">繁體中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734739000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734739000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773542000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773471000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013608\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013608\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013608\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD013608\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013608\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013608\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013608\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013608\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013608\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD013608\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013608\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013608\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013608\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD013608\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013608\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013608\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013608\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD013608\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=9mpoajSI&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD013608.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD013608.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD013608.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD013608.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD013608.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740728232237"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD013608.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740728232241"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD013608.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918ebf75dd59f46e',t:'MTc0MDcyODIzMy4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 